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Streptococcus pyogenes is a bacterium that colonises the human oropharynx 
asymptomatically. It is also a common cause of mild skin and throat infections. 
These can develop into invasive tissue disease and post-immune sequelae. In order 
to understand how S. pyogenes causes disease, several animal models have been 
used. My study has developed and interrogated the zebrafish embryo systemic 
model of infection.  
 
The first part of this work, involved analysis of the virulence of the H293 (emm89), 
H305 (emm1), and HSC5 (emm14) S. pyogenes strains, via zebrafish embryo 
survival assays. This revealed that H293 was the least virulent, and thus more 
amenable to study within experimental parameters. A study of bacterial population 
dynamics during infection suggested the presence of a bottleneck, where the 
immune system regulates growth of S. pyogenes for up to 8 hours post-infection. 
After this point, with an infectious dose that leads to approximately 50% host 
survival, either rapid bacterial growth and host mortality or decline in bacterial 
numbers was seen. Intravital microscopy revealed that phagocytes ingest S. 
pyogenes very early after infection, with macrophages containing more bacteria than 
neutrophils. Interestingly, by 8 hours post-infection, macrophages were found 
completely saturated with bacteria or empty, with concomitant extracellular S. 
pyogenes. The role of phagocytes as the immunological bottleneck was verified as 
their ablation led to uncontrolled bacterial proliferation. The role of other bacteria, 
and their products, in the initiation of S. pyogenes infection was then determined.  
 
Based on my findings, I have established a temporal and spatial model of S. 
pyogenes infection in the zebrafish embryo. This sets the scene for the 
determination and analysis of host-pathogen interactions to aid the development of 
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ºC  Degrees Celsius 
BHI  Brain heart infusion 
BSA  Bovine serum albumin 
CFU  Colony forming units 
dH20  Distilled water 
DMSO  Dimethyl sulphoxide 
DNA  Deoxyribonucleic acid 
dpf  days post fertilisation 
dpi  days post infection 
Fc   fragment crystallisable domain of immunoglobulin molecules 
Fg   Fibrinogen 
g   Grams 
GFP  Green fluorescent protein 
hpi  Hours post infection 
h  Hours 
kV   Kilovolts 
L  Litre 
LWT   London wild-type 
M  Molar 
mg   Milligrams 
mL   Millilitres 
mM   Millimolar 
min  Minutes 
MO   Morpholino oligonucleotide 
nL  nanolitre 
nm   nanometre 




PAMP   Pathogen-associated molecular pattern 
PBS   Phosphate buffered saline 
PG   Peptidoglycan 
RNA   Ribonucleic acid 
rpm   Revolutions per min 
STSS   Streptococcal toxic shock syndrome 
TCR   T-cell receptor 
Tet   Tetracycline 
THY  Todd-Hewitt broth 
TLR   Toll-like receptor 
TSB  Tryptone Soya broth 
v/v   Volume for volume 
WT   Wild-type 
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Chapter 1: Introduction 
 
1.1 S. pyogenes classification 
 
Streptococcus pyogenes, also known as Group A Streptococcus (GAS), is a Gram-
positive β-hemolytic bacterium, within the phylum of Firmicutes, that is restricted to 
human hosts (Bessen, 2009). It can grow either in pairs (diplococci) or in chains, is 
non-motile, and a facultative anaerobe.  One of the early ways of classifying the 
Streptococci, and that is still routinely used, is the Lancefield serological grouping 
system. Species-specific ‘Lancefield’ carbohydrates on the surface of the bacterium 
are detected using antisera that are specific to the antigen type. For instance, Group 
A Streptococcus can be classified as such after confirming antisera reaction with its 
‘type A’ antigen, which is a highly conserved polysaccharide of N-acetyl-β-D-
glucosamine anchored onto a polyrhamnose backbone (Reglinski and Sriskandan, 
2015). Other types include B-D and F-H, while there are Streptococci that do not 
have these antigens, such as Streptococcus pneumoniae. Prior to the advent of 
molecular techniques, M type-specific antisera were used to distinguish different S. 
pyogenes serological M types. Now, sequencing the 5’ variable region of the emm 
gene (coding for the M protein), that ends up forming the N-terminus of the M protein, 
is used instead. Although, more than 200 emm types have been identified, the ten 
most prevalent types comprise about 70% of invasive S. pyogenes infections 
(O’Loughlin et al., 2007, Luca-Harari et al., 2009, Bessen and Lizano, 2010). T 




isolates, by serum recognition of the backbone subunit of the S. pyogenes pilus (T 
antigen) (Lancefield and Dole, 1946, Johnson et al., 2006). 
 
1.2 S. pyogenes infections 
 
The vast majority of reported S. pyogenes infections are either throat infections, with 
more than 600 million cases, or skin infections, with more than 100 million per annum 
(Carapetis et al., 2005). There are estimated to be 2 million new cases of S. 
pyogenes infections every year (Carapetis et al., 2005). Severe S. pyogenes 
diseases in total cause at least 500,000 deaths each year globally, with the greatest 
burden coming from rheumatic heart disease. 
 
1.2.1 Tissue tropism 
 
Many years of S. pyogenes epidemiology studies revealed a number of S. pyogenes 
emm types to be strongly associated with either pharyngitis (throat infection) or 
impetigo (superficial skin infection), rarely changing these observed tissue infection 
tendencies (McGregor et al., 2004, Bessen and Lizano, 2010). Other emm types 
were reported to consistently cause both infections. This alludes to some degree of 
specialisation within S. pyogenes. In order to systematically define these tissue 
tropisms, five emm patterns were assigned (A-E), based on sequence differences 
of the cell wall-spanning domain of the emm locus, and its close emm-like paralogs 




markers for tissue tropism with A-C being throat specialists, D being skin specialists, 
and E generalists (Figure 1.1B) (Bessen et al., 2008, Bessen 2009, Bessen and 




Many bacterial pathogens can asymptomatically colonise the host, such as S. 
pyogenes, Staphylococcus aureus, and Streptococcus pneumoniae (Bogaert et al., 
2004, Yazdankhah, 2004, Shaikh et al., 2010). Despite our many advances in 
understanding bacterial pathogenesis, it is still not known how and why these 
bacteria switch from carriage to the disease state. S. pyogenes usually colonises 
the naso- and oropharynx, and carriers can carry it regardless of any history of 
clinical symptoms (Martin, 2004). S. pyogenes has been reported to occur (carriage) 
in 5-15% in children (Shaikh et al., 2010). In general, the throat and skin areas of 
the human host are the primary reservoirs of S. pyogenes, and transmission occurs 


























Figure 1.1 Emm patterns and their tissue tropism groupings 
(A)Genetic map of the emm chromosomal region indicating emm genes, downstream or 
upstream emm-like genes, and their respective emm patterns. 
(B)Categorisation of 5,439 S. pyogenes isolates according to pharyngitis or impetigo 
isolates, and their emm pattern.  





1.2.3 Non-invasive infections 
 
Throat infections 
The biggest reservoir of S. pyogenes in humans is Waldeyer’s ring in the pharynx, 
a mucosal-associated lymphoid tissue that includes the tonsils (Watson et al., 2016). 
S. pyogenes can infect the human pharynx and cause pharyngitis or tonsillitis. 20-
30% of all pharyngitis is being attributed specifically to S. pyogenes (Reglinski and 
Sriskandan, 2015). Emm types 1-4, 12, and 28, have been reported to be the most 
dominant types in the US and Canada causing these infections (Shulman et al., 
2009). Pharyngitis symptoms include soreness of the throat as well as swollen lymph 
nodes and fever as the immune system attempts to combat the infection. 
Additionally, if the infecting S. pyogenes produces any superantigens, it can induce 
scarlet fever. This leads to inflammation of the tongue that gives the distinctive 
‘strawberry’ patterning of scarlet fever, and is discussed in more detail below 
(Cunningham, 2000). Pharyngitis has also been associated with Acute Rheumatic 
Fever (ARF), an autoimmune sequela caused by S. pyogenes, discussed in 1.2.5. 
 
Skin infections 
Skin infections of S. pyogenes are classified according to how deep the infection 
has reached. The most common of such infections is (superficial) impetigo, and is 
characterised by skin lesions on the face or extremities, that are easily transmitted 
by contact (Stulberg, et al., 2002). Superficial impetigo pustules can lead into deep 
impetigo (ecthyma), when S. pyogenes penetrates the epidermis further and 




heal without scarring, ecthyma ones can cause pain and prove scarring. Treatment 
with oral broad-spectrum antibiotics, such as flucloxacillin, should systemic 
ulceration arise, is suggested as it protects against potential co-infection with 
Staphylococcus aureus (Reglinski and Sriskandan, 2015). Skin infections have been 
linked to post-streptococcal glomerulonephritis (PSGN), discussed in more detail in 
1.2.5. 
 
1.2.4 Invasive infections 
 
Many superficial infections can evolve into invasive infections that disseminate 
further into deeper tissue via bacteraemic spread, skin wounds, or insect bites 
(Cunningham, 2000).  
 
Cellulitis 
Cellulitis occurs when S. pyogenes invades the dermis and subcutaneous tissues, 
and causes inflammation. Oral or parenteral administration of penicillin combined 




Wounds, blunt trauma, and greater than first-degree burns, can predispose a patient 
to Necrotizing Fasciitis (NF), and allow S. pyogenes to penetrate deep into 
subcutaneous tissues progressively destroying fat and fascia (Bisno and Stevens, 




and their later violet colouration, at the soft tissue of extremities. However, the 
swelling could also be associated to the original trauma, whereas the violet colour, 
to potential cellulitis. Hence, while correct diagnosis of NF is difficult, it is vital as 
antibiotic therapy alone is insufficient (Bisno and Stevens, 1996). Instead, it 
additionally requires drainage and surgical removal of the infected tissues. 
 
Streptococcal Toxic Shock Syndrome 
All S. pyogenes invasive infection types have been reported to be able to lead to 
Streptococcal Toxic Shock Syndrome (STSS). When S. pyogenes produces at least 
one superantigen, along with its other virulence factors, it induces a ‘cytokine storm’ 
mediated by the abnormally high numbers of activated T cells. This leads to 
hypotension and subsequent organ failures. STSS is identified when the following 
have all been observed: hypotension, at least two body system failures, and isolation 
of S. pyogenes from a normally sterile site (Reglinski and Sriskandan, 2015). STSS 
manifests early as fever, vomiting, and diarrhoea, all non-specific symptoms. 30-
60% of patients succumb within 72 to 96 hours (Stevens, 2000). Use of adjunct 
intravenous immunoglobulin G (IVIG) therapy against STSS has been suggested, 
due to reported protection via a strong anti-SAg antibody response, however its 






Scarlet Fever (SF) is a disease that develops from an S. pyogenes throat infection 
and is thought to be caused by the production of superantigens (Cunningham, 
2000). It is characterised by the inflammation of the tongue giving it a characteristic 
rash. Although, SF was one of the main diseases that led to S. pyogenes-associated 
deaths at the end of the 19th century, it later saw a decline as the living conditions 
improved and antibiotics were introduced (Krause, 2002). However, new cases have 
been emerging in Hong Kong and mainland China since 2011, as well as in the UK 
since 2014 (Davies et al., 2015, Brouwer et al., 2019, Lynskey et al., 2019).  
 
The Hong Kong and China cases were found to be emm12 and emm1 lineages that 
had acquired prophage elements conferring expression of two superantigens, 
streptococcal superantigen A (SSA) and streptococcal pyrogenic exotoxin C (SpeC), 
the DNase Spd1, as well as multidrug resistance (Davies et al., 2015, Brouwer et 
al., 2019). 
 
In 2016, England specifically saw an increase in invasive S. pyogenes infections 
along with its seasonal elevation of SF (Lynskey et al., 2019). Albeit a hypervirulent 
emm1 strain being the most frequently reported cause of invasive S. pyogenes 
disease since the mid-1980s, the current upsurge of SF in the UK is being caused 
by many different emm types with emm3, emm12, emm1, and emm4 dominating 
(Aziz and Kotb, 2008, Turner et al., 2016, Lamagni et al., 2018). Lynskey and 




different from other pandemic emm1 strains, was found to be the leading cause of 
both the 2014-2016 UK seasonal elevations of SF, as well as the increase in invasive 
infections (Lynskey et al., 2019). Specific mutations in the M1UK lineage are linked 
to higher levels of expression of the streptococcal pyrogenic exotoxin A (SpeA), a 
phage-encoded superantigen that is both necessary for nasopharyngeal infection 
and proved a key factor for the epidemic spread of emm1 in the 1980s (Kasper et 
al., 2014). 
 
1.2.5 Autoimmune sequelae 
 
S. pyogenes infections can also lead to post-infection immune sequelae. These 
diseases can severely damage different organ systems, such as the kidneys in post-
streptococcal glomerulonephritis (PSGN), and joints and heart in Acute Rheumatic 
Fever (ARF) (Cunningham, 2016). Data from both diseases suggest that molecular 
mimicry between streptococcal antigens and specific host molecules is the 
underlying reason why the immune system attacks and damages the host itself. Both 
PSGN and ARF, which are believed to be caused by persistent S. pyogenes 
infection, can be prevented by timely antibiotic administration. As a result, they are 
generally no longer seen in high income countries, which is not the case for low and 
middle income countries. In both ARF and PSGN, the S. pyogenes antigen 
responsible for the molecular mimicry has been reported to be the M protein 
(Adderson et al., 1998, Cunningham, 2014). The M protein is structurally similar to 




is also structurally similar to the kidney molecules collagen and laminin (Michael et 
al., 1966, Kefalides et al., 1986, Cunningham, 2000). PSGN is characterised by the 
presence of blood or sediments in urine, oedema, and high blood pressure, whereas 
RHD by the severe damage of the heart. PSGN and ARF have been reported to not 
coexist in the same host, which was also confirmed with different emm types being 
associated with each one specifically. 
 
1.2.6 Emm global epidemiology 
 
A recent review of S. pyogenes invasive disease epidemiology from Europe, USA 
and Canada (2000-2017) reported that emm1 was the most common followed by 
emm28, 89, 3, 12, 4 and 6 (Gheradie et al. 2018) (Figure 1.2).  
 
One of the most prevalent S. pyogenes genotypes globally is emm/M1, and the rise 
of the M1T1 hypervirulent isolate was reported at the same time as the resurgence 
of invasive S. pyogenes infections the last 30 years (Cole et al., 2011). One of the 
factors that gave M1T1 its virulence, and genetically differentiated it from previous 
M1 variants, was the acquisition of two new prophages (Cleary et al., 1998). This 
new event resulted in M1T1 being able to produce SpeA and the DNase Sda1. 
Additionally, M1T1 also acquired a 36-kb region of the M12 chromosome which had 
as a consequence the upregulation of SPN and Streptolysin O (SLO) (Sumby et al., 
2005, Azirk et al., 2005). Additionally, a spontaneous mutation in the genes of the 




demonstrated to further increase the virulence and dissemination capability of this 
clone, since it can upregulate virulence factor expression including Sic, SLO, and 
SpyCEP (Cole et al., 2011). 
 
From 2000 to 2017, emm89 has been one of the most dominant genotypes causing 
invasive disease in high income countries (Figure 1.2). In Europe, it has been in the 
top 3 of emm types; in Portugal, France, Denmark, Iceland, Sweden and Finland. It 
has also been one of the most prevalent but fluctuating in Norway, Germany, and 
the UK. The genotype has also been reported to be one of the most occurring ones 
in the US (top 5 fluctuating) and Canada (top 2 from the Toronto/Peel and the of 
province of Ontario) (Gherardi et al., 2018). There has been a dramatic increase in 
infections caused by emm89 in the UK over the past 10 years which contributed to 































Figure 1.2 Geographical distribution of the most prevalent invasive S. pyogenes emm 
types  
A map of the distribution of the most prevalent S. pyogenes emm types that caused invasive 
disease in Europe (A), and North America (B). Data from epidemiology studies from different 






1.3 S. pyogenes virulence factors 
  
1.3.1 Surface-associated virulence factors 
   
1.3.1.1 M protein 
 
The M protein is a cell wall-anchored protein that is fibrillar and is found on all S. 
pyogenes strains (Figure 1.3). It is one of the most studied virulence factors of S. 
pyogenes, and it has been found to have roles in adhesion, phagocytosis resistance, 
and interaction with neutrophils (McNamara et al., 2008). With regards to adhesion, 
S. pyogenes uses its M protein to bind to host cells or components of the 
extracellular matrix, including collagen and fibronectin (Dinkla et al., 2003, 
Smeesters et al., 2010, Bober et al., 2011). M protein can additionally interfere with 
opsonisation and phagocytosis by binding to host proteins, and subsequently 
recruiting them to cover the surface of S. pyogenes. More specifically, the C4b 
binding protein (C4BP), once recruited, still acts as a complement inhibitor 
(Johnsson et al., 1996, Johnsson et al., 1998, Berggard et al., 2001). Plasma 
components, like albumin and fibrinogen can also be bound, which protects against 
complement deposition (Carlsson et al., 2005, Smeesters et al., 2010).  
 
The M protein was also found to maintain its important role in virulence even after 
being cleaved to its soluble form by either human proteases or the streptococcal 




molecules that has been shown to bind to β2-integrins on the surface of neutrophils 
causing the neutrophil to be activated and release heparin-binding protein (HBP) 
(Herwald et al., 2004, Macheboeuf et al., 2011). This release of HBP, leads to 
vascular leakage and hence sepsis and shock (Linder et al., 2009). Furthermore, it 
has been reported that M protein, in its cleaved form, has pro-inflammatory 
properties (Pahlman et al., 2006), as well as the ability to induce massive T-cell 
activation which consequently induces a ‘cytokine’ storm (Pahlman et al., 2008). 
Observations have also been made suggesting that the M protein may contribute to 
invasive S. pyogenes infections by interacting with endothelial and epithelial cells 




S. pyogenes cell envelope proteinase (SpyCEP), is a protease on the surface of S. 
pyogenes that cleaves and inactivates interleukin (IL)-8 (Edwards et al. 2005). This 
results in a decrease in neutrophil recruitment, neutrophil-induced bacterial killing, 
and dissemination (Zinkernagel et al., 2008, Kurupati et al., 2010). Although, 
generally residing on the surface of S. pyogenes, SpyCEP has also been reported 
to be readily released, and phagocytosed by endothelial cells to impede neutrophil 
migration to the site of infection (Reglinski and Sriskandan, 2015). SpyCEP is 
expressed in higher levels in invasive clinical isolates as opposed to non-invasive 





























Figure 1.3 Surface-associated S. pyogenes virulence factors 
Diagram of membrane-bound S. pyogenes evasins (written in blue), and their interactions 
with host proteins (written in black). (1)M proteins, (5)Hyaluronic capsule as described in 
Section 1.2.1. FbaA(2) and Scl1(3) bind Factor H (H), one of the complement inhibitors that 
targets the CP/LP and AP convertases. Fibronectin-binding protein Sfb1/PrtF1(4) impairs 
C3b deposition. (6)GAPDH is generally cytosolic, but has also been described to be sent to 
the bacterial surface. The CP C5a peptidase(7) cleaves C5a, C3, and C3a. Vibronectin-
binding protein(8) has been reported to interfere with the MAC assembly, but its exact role 
as a S. pyogenes evasin is unknown, as indicated by the question mark. Taken from (Laabei 





1.3.1.3 Hyaluronic acid capsule 
 
The hyaluronic acid (HA) capsule is a viscous material made up of polymers of 
glucoronic acid and N-acetylglucosamine units (Cunningham, 2000). It is produced 
de novo and deposited on the surface of S. pyogenes covering it. Not all emm types 
have an HA capsule, as emm4 and emm22 lack the entire hasABC operon. 
Although, both HasA and HasB are needed for the synthesis of glucoronan, HasC 
is not (Alberti et al., 1998, Ashbaugh et al., 1998). A hasB homologue (hasB2) was 
found and was demonstrated to act as an additional UDP-glucose dehydrogenase 
for the production of HA (Cole et al., 2012). The second part of the HA repeating 
unit, N-acetylglucosamine, is synthesised as a by-product of cell wall production.  
 
The HA capsule functions as a physical barrier for S. pyogenes, and hinders 
interactions between immune system effectors and pathogen-associated molecular 
patterns (PAMPs) on the surface of S. pyogenes, as well as being very important at 
establishing S. pyogenes during the initial stages of infection (Cunningham, 2000, 
Schrager et al., 1998). S. pyogenes HA is chemically identical to eukaryotic HA, 
found on cell surfaces, connective tissues, and the extracellular matrix, which allows 
the pathogen to mimic host antigens and evade the adaptive immune response 
(Cunningham, 2000, Cole et al., 2012). Furthermore, the HA capsule protects S. 




peptide LL-37 when trapped in neutrophil extracellular traps (NETs) (Cole et al., 
2010). This promotes S. pyogenes survival by interfering with the role of LL-37 as a 
chemoattractant. 
 
HA may be important for establishment of S. pyogenes during the initial stages of 
infection. The host cell surface HA receptor CD44 is present on the pharyngeal 
epithelium and the epidermis, and is upregulated during injury or inflammation 
(Schrager et al., 1998). S. pyogenes has been found to be able to bind to CD44 on 
human keratinocytes (Cunningham, 2000, Schrager et al., 1998). Hence, given the 
expression of CD44 in both skin and pharynx, and the conservation of hasABC in S. 
pyogenes, the HA-CD44 interaction might be key to the initial stages of infection. 
Hyper-encapsulated strains have been reported to cause extensive tissue damage 
at the site of infection and secondary bacteraemia in mice skin infection, whereas 
their isogenic acapsular clones induced a mild, self-resolving infection restricted at 
the site of infection (Schrager et al., 1996). This suggests that the HA capsule can 
play a key role in establishing S. pyogenes upon entry. Binding to CD44 was also 
found to trigger host cytoskeletal ruffling to initiate S. pyogenes movement into 
deeper tissues through or around the host cells (Cywes and Wessels, 2001). 











The streptococcal cysteine protease SpeB, is secreted as a 40 kDa inactive 
zymogen that is converted into its mature 28 kDa form via autocatalysis (Carroll and 
Musser, 2011). It is secreted by all sequenced strains, as seen in both mice and 
patients, but expression varies among emm types (Cole et al., 2011, Laabei and 
Ermert, 2019). A loss of function mutation of speB yielded reduced skin lesions, 
tissue damage, bacterial dissemination, and mortality in mice (Nelson et al., 2011). 
A study that analysed more than 9000 clinical isolates, reported that the 
overwhelming majority of the ones causing invasive disease secreted SpeB (Olsen 
et al., 2015). However, there are some isolates derived from emm types associated 




























Figure 1.4 Secreted S. pyogenes virulence factors 
Diagram of secreted S. pyogenes virulence factors (written in blue), and their interactions 
with host components (written in black) as described in Section 1.2.2. The action of SpeB 






SpeB is able to degrade both host and S. pyogenes virulence factors. Cleavage of 
E-cadherin and occludin, as well as ECM fibronectin and vitronectin, allows S. 
pyogenes to penetrate the epithelial barrier, and invade deeper tissues (Kapur et al., 
1993, Sumitomo et al., 2013). SpeB can also hinder complement activation and 
neutrophil killing by degrading complement factors, such as the C1 inhibitor, C2, 
C3b, C5a, C9, and properdin (Figure 1.4) (Kuo et al., 2008, Terao et al., 2008, 
Honda-Ogawa et al., 2013). More specifically, a study showed that the absence of 
SpeB, resulted in increased deposition of C3 fragments on S. pyogenes A20 (Kuo 
et al., 2008). A20 is an M1T1 type, that was isolated from a patient with necrotizing 
fasciitis. A20 was found to be more resistant to neutrophil killing in SpeB-treated 
serum, when compared to normal serum, with the killing returning with the addition 
of purified C3. These observations were supported in vivo by a study reporting no 
detection of C3 (C3b) in sera from the sites of infection in STSS patients (Terao et 
al., 2008). Additionally, SpeB can degrade immunoglobulins, chemokines, 
fibrinogen, plasminogen, and the antimicrobial peptide LL-37 (Collin and Olsen 
2001, Schmidtchen et al., 2002, Egesten et al., 2009, Nelson et al., 2011). 
 
Virulence factors can also be proteolytically cleaved by SpeB suggesting that S. 
pyogenes can regulate its own virulence. SpeB can degrade the M protein, 
fibronectin-binding proteins, the plasminogen activator streptokinase, and the 
DNase Sda1 (Svensson et al., 2002, Cole et al., 2006, Walker et al., 2007, 
Sanderson-Smith et al., 2008, Nelson et al., 2011). In addition, SpeB has proteolytic 




enzymes, and the secreted inhibitor of complement (SIC) (Aziz et al., 2003, Terao 
et al., 2008, Honda-Ogawa et al., 2013). Plasmin-coated S. pyogenes can invade 
deeper tissues by breaking down tissues and extracellular matrix components. The 
lysis of the DNase Sda1 by SpeB also prevents S. pyogenes clearance from 
extracellular traps (Cole et al., 2006). Therefore, this significant control of virulence 
must be carried out by a complex system, but the underlying mechanisms are still 
elusive. It has been suggested that SpeB regulation is carried out by a combination 
of environmental cues and intrinsic regulators, including the regulator of protease B 
(RopB), the multiple gene regulator protein (Mga), and the CovRS system (Ribardo 




S. pyogenes causes vascular dysfunction, sepsis and toxic shock via superantigens 
and two secreted streptolysins; O (SLO) and S (SLS). These two hemolysins induce 
cell death of host red blood cells, neutrophils, and platelets via pore formation, as 
well as degrading epithelial junctions between host cells (Figure 1.4) (Goldmann et 
al., 2009, Timmer et al., 2009, Sumitomo et al., 2011).  
 
SLO toxin is secreted and binds to the plasma membrane of host cells as a 
monomer., The monomers then oligomerise, and start transitioning through a few 
steps before they eventually create a circular pore complex with a diameter of 30 




SLS is produced and deposited on the S. pyogenes surface to then either be 
delivered on host cell membranes, to induce pore-forming-driven death, or bind 
calpain and E-cahedrin to facilitate the breaking down of tight junctions (Sumitomo 
et al., 2011). A mechanism that has been recently elucidated however, is that of 
pore-forming-mediated cell death by SLS. High-resolution live cell imaging has 
shown that SLS pores disrupt band 3, an anion exchange protein, on the surface of 
erythrocytes, which causes a dramatic influx of Cl- ions into the cell, and its 
subsequent lysis (Higashi et al., 2016). In vivo microscopy of embryo and adult 
zebrafish, and mice, revealed that S. pyogenes strain HSC5 producing SLS, is able 
to impede migration of neutrophils to the infection site, when compared to its SLS-
mutant (Lin et al., 2009). This observation was also associated with decreased host 
survival for wild type HSC5. 
 
1.3.2.3 Complement inhibitors 
 
Endopeptidase O (PepO) 
Endopeptidase O or PepO was shown to bind to C1q, an initiator of the classical 
complement pathway, at a higher affinity than IgG, preventing IgG from binding to 
C1q (Figure 1.4) (Honda-Ogawa et al., 2017). A pepO deletion mutant, proved to be 
more susceptible to the bactericidal activity of human serum in vitro. In vivo, pepO 
mutant-infected tissues showed reduced infection severity and higher complement 
activity in a mouse skin infection model. Hence, data suggests that S. pyogenes can 
evade the complement system by using PepO to prevent IgG from being engaged 




regulator of SpeB, using the emm1 type S. pyogenes strain 5448 (Brouwer et al., 
2018). They also confirmed the aforementioned in vivo observations when using a 
pepO mutant in mice. It is therefore unclear how much the susceptibility seen in the 
pepO mutant comes from its effects on SpeB or from its effects on C1q. 
 
Streptococcal inhibitor of complement (SIC) 
The thick outer wall of peptidoglycan of Gram-positive bacteria has been reported 
to confer resistance from the membrane attack complex (MAC)-mediated lysis 
(Joiner et al., 1983). Yet, the streptococcal inhibitor of complement (SIC) has been 
shown to interact with MAC directly in vitro, and was suggested to interfere with the 
complement system via MAC (Fernie-King et al., 2001). Although, it is still not known 
which one of these findings is relevant, SIC-deleted S. pyogenes strains exhibited 
reduced survival in saliva, a finding which was also seen in a mouse oropharyngeal 
infection model, hence there is a potential role of SIC for combatting the host 
immune system (Lukomski et al., 1999, Shelburne et al., 2005). SIC has only been 
found to be expressed by emm1 strains. 
 
A recent study reported that SIC binds to histones H3 and H4, and boosts pro-
inflammatory cytokine production (Westman et al., 2018). SIC could bind to both H4 
and TLR4 on monocytes and macrophages, and result in IL-6 production. Additional 
SIC ligands were found to induce an increased inflammatory response including LL-
37, a neutrophil and eosinophil chemoattractant. Taken together with the previously 




authors hypothesised that SIC can both create a non-inflammatory and an 
overwhelmingly inflammatory environment, depending on whether S. pyogenes is 
colonising asymptomatically or is causing invasive disease. More specifically, the 
highest levels of sic expression were seen when S. pyogenes was incubated in 
blood (Westman et al., 2018). 
 
1.3.2.4 IgG degrading proteins 
 
Immunoglobulin G (IgG) is the most ubiquitous antibody type in human serum, 
opsonises the bacteria, and activates the complement system via the classical way 
by binding to C1q at its Ig Fc region (Noris and Remuzzi, 2013, Laabei and Ermert, 
2019). This engages the Fcγ receptors on phagocytes, and results in 
opsonophagocytosis and further chemoattraction. S. pyogenes can produce 
IdeS/Mac-1 and EndoS that can both neutralise this pathway. 
 
IdeS/Mac-1 
IdeS/Mac-1 owes its name to its homology with the α-subunit of human Mac-1, a 
leukocyte β2 integrin (Lei et al., 2001).  It is a 35-kDa cysteine endopeptidase that 
specifically binds to IgG, and is produced by many S. pyogenes strains (von Pawel-
Rammingen, 2012). IdeS cleaves IgG at the lower region of the heavy chain, 
rendering Fcγ engagement impossible. The resulting antibody fragments can bind 
to S. pyogenes, but are unable to elicit a complement response, constituting a 




the membrane of human neutrophils and abrogate opsonophagocytosis and 
following production of reactive oxygen species (ROS) (Lei et al., 2001). This 
resulted in significantly higher S. pyogenes survival. 
 
EndoS 
EndoS is a 108-kDa endoglycosidase that targets the glycan at asparagine-297 of 
the heavy chain of IgG, required to interact with Fcγ receptors on the surface of 
phagocytes (Collin and Olsén, 2001b). This alludes to interference with classical 
activation of the complement via IgG. Whereas a study confirmed this, and reported 
that EndoS prevents binding of IgG to Fc receptors, and increases S. pyogenes 
survival in human blood ex vivo (Collin et al., 2002), another reported that 
mutagenesis of ideS or EndoS in M1T1 S. pyogenes, did not curtail resistance to 
phagocytosis or reduce virulence in a systemic mouse model of infection (Okumura 
et al., 2013). Therefore, these mechanisms are yet to be properly elucidated.  
 
1.3.3 Virulence genes and regulation 
 
Virulence Genes 
The size of the S. pyogenes genome is about 1.9 Mb and sequencing the whole 
genome of 12 isolates indicated that more than 85% of all genes were conserved 
among the strains (Beres and Musser, 2007). These conserved genes, also known 
as the core genome, share a 98% nucleotide identity. Another approximately 10% 




mobile genetic elements, the majority of which were bacteriophage genomes 
(prophages) (Ferretti et al., 2001, Banks et al., 2004). 
 
S. pyogenes virulence factor genes are scattered throughout the genome, unlike in 
pathogens such as S. aureus that has them grouped in pathogenicity islands. 
However, there are two pathogenicity island-like clusters; the emm cluster and the 
FCT region. The emm cluster is a group of S. pyogenes virulence factors located 
around the emm gene, coding for factors such the M protein, the C5a peptidase and 
SIC (Ferretti et al., 2001, Beres and Musser, 2007). Both the sequence and the 
chromosome location of the emm cluster have been shown to be highly conserved. 
The fibronectin-binding, collagen-binding, T antigen (FCT) region can be found in 
many S. pyogenes strains, and it carries genes for extracellular factors that promote 
attachment to human cells in the skin and pharynx (Bessen and Kalia, 2002, Mora 
et al., 2005, Abbot et al., 2007). The genes for pilin and full-length pilus protein 
production and cell wall attachment genes have been identified in this region (Telford 
et al., 2006). There have been reported at least nine variants of this region, which 






Mobile Genetic Elements 
Mobile genetic elements (MGEs) are DNA sequences that encode proteins involved 
in the movement of genetic material from one bacterial chromosome to the next 
(Frost et al., 2005). They can be detected by their difference in G+C content 
compared to the genome they are found in, as well as from specific genetic elements 
they carry facilitating lateral gene transfer (Ferretti et al., 2001, Frost et al., 2005, 
Panchaud et al., 2009). There are three types of MGEs: insertion sequences (IS), 
prophages, and integrative and conjugative elements (ICEs) (Ferretti et al., 2001). 
Prophages are responsible for most of S. pyogenes strain to strain variations in 
virulence. They can often carry one or more genes for virulence, (Reglinski and 
Sriskandan, 2015). Examples of prophage and prophage-like element associated 
genes include ones expressing superantigens (speA, speC, , speH, speI, speK, 
speL, ssa), DNases (spd1, mf2, mf3, mf4), phospholipase A2 (sla), and macrolide 
resistance (mefA) (McShan and Nguyen, 2016). ICEs are DNA regions that can self-
transmit between bacterial genomes via conjugative transfer (Burrus and Waldor, 
2004). Twelve ICEs have been reported in S. pyogenes, expressing virulence 





Virulence Gene Regulation: Standalone Regulators 
Virulence gene regulation in S. pyogenes is coordinated by 12 highly conserved two-
component systems, and at least 30 transcription regulators (Vega et al., 2016). 
They combine environmental cues with S. pyogenes' own metabolic state, and 
currently expressed genes, into a unified response.  
 
Mga 
Mga (multiple gene activator of S. pyogenes) is a transcriptional positive regulator 
that is highly conserved and is situated in the emm cluster having two alleles: mga-
1 and mga-2 (Kreikemeyer et al., 2003, Hause and McIver, 2012). Its core regulon 
includes emm cluster virulence genes (emm, scpA, sic), the serum opacity factor 
gene (sof), and the streptococcal collagen-like protein genes (sclA, sclB). Mga is at 
its peak activity during the exponential growth phase under normal growth 
conditions, while also being induced in response to growth-limiting conditions, such 
as low iron and/or increased CO2 concentrations, as well as higher temperatures 
(Vega et al., 2016). Hence, this data suggests that the timely upregulation of the 
colonisation and immune evasion factors controlled by Mga is important to enable 
S. pyogenes to progress into deeper tissues, after it has established the local 
infection. While Mga is active during exponential growth, there are other 
transcriptional regulators, such as ones from the RALP and Rgg families, that mostly 
act during the stationary growth phase (Vega et al., 2016). These factors have the 






The RALP (RofA-like protein) family is a group of four individual transcriptional 
regulators: RofA, Nra, RALP-3, and RALP-4/RivR. The RALP family is believed to 
drive S. pyogenes persistence during the stationary phase via upregulation of 
adhesins and downregulation of tissue damaging factors (Kreikemeyer et al., 2003). 
RofA and Nra have been studied the most and have been reported to exert their 
activity upon the FCT region. They both can repress SpeB and SLS transcription, 
while Nra can also silence SpeA (Panchaud et al., 2009, Siemens et al., 2012). Co-
activation of RALPs and the fibronectin binding protein Sfb1, boosts attachment and 
penetration of host cells allowing S. pyogenes to switch from a colonisation to a 
persistence phenotype during stationary growth. In addition to being able to repress 
Mga, Nra can also exert such an activity on RALP-3, RALP-4, and Rgg/RopB 
(Podbielski et al., 1999, Kreikemeyer et al., 2007) 
 
Rggs 
The Rgg/GadR/MutR family of transcription factors are widespread in the Firmicutes 
phylum, and S. pyogenes expresses four paralogs: Rgg/Rgg1/RopB, ComR, Rgg2, 
and Rgg3 (Chang et al, 2011). All Rgg proteins affect gene expression during 
stationary growth. Rgg/RopB controls the expression levels of SpeB depending to 
the growth phase, with maximum production of SpeB at the stationary phase (Lyon 
et al., 1998, Chaussee et al., 1999, Unnikrishnan et al., 1999). It was also found to 
downregulate the transcription of genes including speH (superantigen), Mga targets 
(sclA, emm, scpA, slo), ska, the hasABC operon, and mac in NZ131 (M49) 




influence other regulator genes, such as mga, as well as genes from the two-
component systems CovRS and FasBCAS/X (Vega et al., 2016). RopB was 
additionally found to affect the stationary phase expression of genes involved in 
metabolism (Chaussee et al., 2003, Chaussee et al., 2004, Dmitrievet al., 2006).  
 
Rgg2 and Rgg3 (ordered according to their similarity to RopB) have been described 
as cytoplasmic quorum-sensing receptors, affecting virulence factor gene 
expression, via binding to signalling peptides, also known as autoinducers or 
pheromones (Chang et al., 2011, Federle, 2012). Adjacent to the rgg2 and rgg3 S. 
pyogenes genes, two short hydrophobic peptide (shp) sequences were found for 
each Rgg gene (Ibrahim et al., 2007). These shp peptide products later mature into 
pheromones that bind and activate their Rgg2 and Rgg3 targets (Chang et al., 2011). 
A similar DNA sequence was found near RopB coding for the SIP pheromone 
(Makthal et al., 2018). Moreover, the expression of these shp genes enhances 
biofilm production. Similar to Rgg2 and Rgg3 and their shp pheromones, ComR has 
been shown in Streptococcus mutans and thermophilus to be adjacent to comS, 
which expresses a pheromone that binds to the ComR regulator, and activates it 
(Federle, 2012). Federle reported in 2012, that ComR and ComS work the same 






Virulence Gene Regulation: Two-Component Systems 
Two-component signal transduction systems (TCS) are comprised of two parts; 
signal detection and activation of a responder. The typical example of a TCS is one 
where a transmembrane histidine kinase binds to an external signal molecule, and 
in turn activates a response regulator that controls transcription (Kreikemeyer et al., 
2003, Stock et al., 2012).  
 
CovRS 
The control of virulence (CovRS) system, first characterised as the capsule 
synthesis regulator (CsrRS), consists of the CovS sensor kinase situated on the 
surface of S. pyogenes, and the CovR response regulator in the cytoplasm (Levin 
and Wessels, 1998, Dalton and Scott, 2004). CovS detects extracellular stimuli, 
such as Mg2+ and host antimicrobial peptides, and subsequently phosphorylates and 
activates CovR. CovR in turn modulates the transcription of the target virulence 
genes, mainly facilitating transcriptional repression (Gryllos et al., 2003, Gryllos et 
al., 2008). CovRS is a master regulator of S. pyogenes, given that it was reported 
that it can negatively regulate up to 15% of all genes on the S. pyogenes 
chromosome, including those encoding for SpyCEP, EndoS, SLS, and SLO, but 
positively regulate speB (Heath et al., 1999, Graham, et al., 2002, Dalton and Scott, 
2004). This master regulator was also demonstrated to be able to regulate Mga 





Furthermore, it was reported that CovR is able to modulate its regulon without CovS, 
since covR or covS mutants can have different phenotypes (Treviñο et al., 2009, 
Sumby et al., 2006, Shelburne et al., 2008). A number of studies observed 
hypervirulent S. pyogenes phenotypes that were linked to covRS mutations that 
yielded loss of SpeB synthesis and upregulation of HA capsule and other virulence 
factors (Aziz et al. 2004, Engleberg et al., 2004, Cole et al., 2006, Li et al., 2013). In 
the absence of SpeB, the Sda1 DNase, along with other virulence factors such as 
Streptokinase and M1, can be produced, turn host plasminogen to plasmin, and 
promote systemic spread (Aziz, et al., 2004, Cole et al., 2006, Kansal et al., 2000). 
Higher concentrations of Sda1 also enhances DNA degradation in NETs, which 
enables S. pyogenes to resist neutrophil killing at the site of infection (Buchanan et 
al., 2006, Sumby et al., 2005). Neutrophils were specifically reported to drive the 
selection pressure for covRS mutations (Li et al., 2014). 
 
FasBCA/X 
In the FasBCA/X system in S. pyogenes (fibronectin/fibrinogen binding/hemolytic 
activity/streptokinase -Fas- regulator), FasB and FasC are two predicted histidine 
protein kinases (HPKs) that phosphorylate and activate the FasA response regulator 
(Kreikemeyer et al., 2001, Kreikemeyer et al., 2003, Liu et al., 2012).  FasA triggers 
the expression of a small regulatory RNA downstream of the fasBCA operon, FasX, 
that base pairs with two target mRNAs: streptokinase (ska) and the first gene of the 
pilus production operon cpa (Ramirez-Peña et al., 2010, Liu et al, 2012). In the case 




production, while binding to the cpa mRNA prevents ribosome binding and 
production of the collagen-binding minor pilus protein at the pilus tip. Additional 
activity FasBCA/X has been reported to have is repression of adhesin genes, fbp54 
and mrp, as well as upregulation of sagA, all in a growth-phase-dependent manner 
(Kreikemeyer et al, 2001). These opposing forces of gene regulation suggest that 




The Ihk/Irr TCS promotes S. pyogenes survival and persistence within phagocytes 
of the host innate immune system at the initial stages of infection, in a way that does 
not interfere with phagocytosis or ROS production in neutrophils (Voyich et al., 2003, 
Hertzén et al., 2012).  It was also reported to be expressed at high levels during 
pharyngeal infections (Kreikemeyer et al., 2003, Voyich et al., 2003). In the early 
stages of infection, intracellular S. pyogenes was found to highly express ihk and irr 
along with the hasABC operon and genes involved in energy production (Hertzén et 
al., 2012). Over time, a decrease of this expression profile was noted with 
concomitant elevated levels of covRS transcription. Ihk/Irr can also drive the 
increased transcription of virulence genes, such as sic, mac, speH, endoS, smeZ, 





1.4 S. pyogenes interactions with the immune system 
 
1.4.3 S. pyogenes TLR recognition 
 
Pattern recognition receptors (PRRs) detect the presence of invading pathogens or 
damaged cells in a host when bound to pathogen-associated molecular patterns 
(PAMPs) (Takeuchi and Akira, 2010). One type of PRRs, the TLRs (transmembrane 
Toll-like receptors), are found not only in phagocytes, such as macrophages and 
neutrophils, but also in non-professional immune cells. Activation of TLRs is ligand-
specific, and upregulates the transcription of specific pro-inflammatory genes, 
depending on the type of TLR. The signalling cascade that eventually activates 
those genes requires an adaptor that binds to their cytoplasmic Toll/IL-1R homology 
(TIR) domain (Akira and Takeuchi, 2006). One of the main adaptors, that binds to 
such domain, is the myeloid differentiation primary response protein (MyD88). 
MyD88 leads into a cascade that translocates NF-κB into the nucleus, and 
eventually activates the specific transcription factor to upregulate the target pro-
inflammatory cytokine genes. Cytokines, such as type I interferons (IFNs), 
interleukins (ILs), and tumour necrosis factors (TNFs), are proteins that mediate cell 





It has been reported that MyD88 is required for mounting a successful inflammatory 
response against S. pyogenes (Loof et al., 2008, 2010). It was found that in MyD88-
deficient mice, production of TNF, IL-6, IL-12, and type I interferons (IFNs) was 
significantly lower (Gratz et al., 2008, 2011; Loof et al., 2008, 2010). This was 
associated with inability to recruit neutrophils, and a higher susceptibility to S. 
pyogenes. Furthermore, TNF is also produced downstream of TLR-induced MyD88, 
and results in rapid recruitment of macrophages (Mishalian et al., 2011).  
 
In spite of all this data implicating MyD88 against S. pyogenes, it is still not clear 
which TLRs are engaged (Figure 1.5). A study showed that in mice, TLR2 and 
TLR13, albeit being redundant in vitro, are not in vivo, and are employed to engage 
and combat S. pyogenes (Fieber et al., 2015). TLR2 recognises S. pyogenes at first 
regardless of phagocytosis, and TLR13 then gets engaged after internalisation of S. 
pyogenes. Although TLR2, and its ligand specificity, is conserved between fish and 
mammals (Stein et al., 2007), TLR13 recognises 23S rRNA and is absent from both 
humans and zebrafish. It is present in all kingdoms, but is limited to only a few 
mammals, including mice and rats (Hidmark et al., 2012, Li and Chen, 2012, 
Oldenburg et al., 2012, Fieber et al., 2015). Despite the specific identity of human 
TLRs eluding us, MyD88 was demonstrated to induce the transcription of IFN-β and 

















Figure 1.5 Innate immune response against S. pyogenes 
S. pyogenes is recognised by yet unknown TLRs, that induce MyD88 signalling. MyD88 
upregulates the transcription of cytokines, such as IFN-β, TNF, and IL-6, to promote 
inflammation. TNF promotes the migration of macrophages to the site of infection. IFN-β 
triggers Type I IFN signalling that eventually leads to a balanced migration of neutrophils in 
a process not yet identified. Upon S. pyogenes phagocytosis, S. pyogenes rRNA can bind 
to TLR13, and activate the innate immunity. TLR9 was also shown to drive ROS- and NO-
killing of S. pyogenes. Recognition of S. pyogenes results in IL-1β production in a NLRP3-
dependent manner, the role of which has yet to be elucidated. Taken from (Fieber and 
Kovarik, 2014). 
ROS: reactive oxygen species, NO: nitric oxide, NLRP3: NOD-like receptor family, IFNAR: 





1.4.4 S. pyogenes and phagocytes 
 
Despite the complicated and robust mechanisms of the innate immune system, S. 
pyogenes has been demonstrated to persist not only within the professional 
phagocytes macrophages (Thulin et al., 2006, O’Neil et al., 2016) and neutrophils 
(Medina et al., 2003), but also within epithelial (Marouni and Sela, 2004, Kaplan et 
al., 2006), and endothelial cells (Amelung et al., 2011). A study looking at human 
macrophages reported that S. pyogenes emm1 is able to replicate intracellularly 
(O’Neil et al., 2016). Macrophages were additionally shown to act a reservoir to 
harbour large numbers of viable S. pyogenes, during aggressive intravenous 
antibiotic treatment (Thulin et al., 2006). The M1 protein was additionally suggested 
to interfere with the fusion of enzymolytic vesicles with phagocytosed S. pyogenes 
(Staali et al., 2006; Hertzén et al., 2010). 
 
Furthermore, a study showed that TNF-α deficient mice revealed a significant 
impairment of macrophage recruitment to the site of infection, whilst neutrophil 
numbers recruited were not affected (Mishalian et al., 2011). This was found in a 
cutaneous model resembling necrotizing fasciitis. In order to assert that the TNF-α 
deficiency leading to higher host susceptibility was macrophage-mediated, mice 
were depleted of macrophages. Whilst the number of neutrophils and tissue 
bacterial load remained the same, S. pyogenes dissemination was dramatically 




intravenous or subcutaneous injection. Hence, this study highlighted the importance 
of macrophages in restricting S. pyogenes.  
 
1.4.5 Adaptive immune system 
 
As most S. pyogenes infection models examine innate immunity, the role of the 
adaptive immune response, is much less explored (Fieber and Kovarik, 2014). Mice 
deficient in B and T cells (SCID) inoculated with S. pyogenes, yielded a similar 
survival to control mice, alluding to clearance of S. pyogenes relying more on the 
innate immune system, than the adaptive one (Medina et al., 2001; Goldmann et al., 
2005b). However, due to the lack of data, there is a high chance that the role of the 
adaptive response is greatly underestimated. Patients lacking the TLR signalling 
adaptor MyD88, although being very susceptible to S. pyogenes during their early 
years, become more resistant in adulthood, which suggests that adaptive immunity 
might be able to substitute the innate to some degree (Von Bernuth et al., 2008). To 
further support this point, two mouse studies revealed a key involvement of IL-17-
producing T helper (Th) 17 (or CD4+) cells in clearing S. pyogenes (Wang et al., 





TGF-β1 is a cytokine that is vital to the development of regulatory T cells (Tregs) 
and Th cells, that can be generated by many cell types, such as macrophages and 
dendritic cells (Wang et al., 2010). The first T cell type blocks immune attacks to 
self-antigens, whereas the latter, upregulates macrophage and neutrophil migration 
to the site of infection, resulting in the clearance of the pathogen. It was shown that 
production of TGF-β1 was required for the development of Th cells and IL-17 
production. These primed cells were then transferred into naive mice and enabled 
the mice to clear S. pyogenes. Another study uncovered that the need for IL-17 
production for S. pyogenes clearance, was also dependent on IL-6 production, as 
IL-6-deficient mice were either highly more susceptible to infection or became long-





1.5 Animal models for S. pyogenes infection 
 
Animal models are an excellent platform for elucidating human pathogen infection 
at a holistic level, within the context of an organism, as opposed to focusing on a 
single isolated mechanism (in vitro models), or mathematical or computer models, 
which by their nature are simple and do not allow for the multiplicity of interactions. 
Animals can help identify virulence factors and mechanisms important to medical 
conditions caused by S. pyogenes, as well as interrogate host immune components 
important to combating the pathogen. One of the challenges with creating an S. 
pyogenes model reflects the diverse population of the species, and not many strains 
have been reported to be virulent in any given animal model (Bessen, 2009). As a 
consequence, when considering animal models for most human pathogens, it is 
important to know that no single strain can successfully recapitulate the exact 
infection progression observed in the human body milieu. Despite this limitation, 
animal models can still be used to study specific facets and mechanisms of the 
infectious process. In order to understand S. pyogenes infection, many animal 
models have been established (Figure 1.6). In the following sections, a variety of 








Figure 1.6 Animal models for analysis of S. pyogenes pathogenesis 
The figure summarises the animal models that have been established to study S. pyogenes 
infection. The models are grouped according to the site of infection or colonisation as well 
as colour-labelled, indicating the type of host-pathogen interaction. The key for the animal 







Mice are the primary animal model for studying S. pyogenes infection, with many 
available inbred strains, the ability to knock-out genes or produce transgenic mice, 




Most experiments studying the interactions between S. pyogenes and the pharynx 
in an animal model have been the mouse (Gogos and Federle, 2019). This model is 
referred to as the pharyngeal or mucosal colonisation model, where a volume 
between 2.5 and 100 μL carrying 106-108 bacteria is inserted into the mice via 
inhalation from the nares (Watson et al., 2016). This allows for the bacteria to reach 
the nasopharynx, oropharynx, and nasal-associated lymphoid tissue (NALT). At 
larger volumes, bacteria can also reach the lungs. Bacterial burden is subsequently 
measured by CFU enumeration on plates with bacteria coming either from throat 
swab-inoculated saline or homogenised nasal tissue (Gogos and Federle, 2019). 
 
Female FVB/n mice were challenged with 5 µL of 108 CFU of emm75 S. pyogenes 
or its isogenic ΔcovRS, and the competence of the two strains to persist over 21 
days was examined (Alam et al., 2013). Nose pressing on plates to monitor bacterial 




which confirmed the role of CovRS in the successful S. pyogenes colonisation of the 
pharynx. This data further supports previous reports that pharyngeal isolates from 
patients rarely carry covRS mutations, unlike invasive isolates from patients (Liang 
et al., 2013, Galloway-Pena et al., 2018). This study utilised a new model for mouse 
pharyngeal infection discussed more below. Another study showcased the 
importance of SpeB, along with RopB, during S. pyogenes infection of the pharynx 
(Makthal et al., 2018). CFU counts from infected mice throat swabs showed that 
speB, ropB or the SIP pheromone gene deletions yielded smaller numbers of S. 
pyogenes over 7 days. This underlined the importance of not only SpeB for 
pharyngeal persistence, but also the one of cell-cell communication. 
 
Mice have also been able to allow for analysis of immunisation against S. pyogenes. 
Anti-M protein secretory IgA was delivered into the nares of the mice, and was found 
to protect against systemic infection, following intranasal inoculation of S. pyogenes 
(Bessen and Fischetti, 1988). Active immunisation was also studied when peptide 
vaccines were delivered intranasally, and demonstrated protection (Olive et al., 
2002, Olive et al., 2006). 
 
One of the weaknesses of this mouse model is that rodents do not have a 
Waldeyer’s ring homologue and hence tonsils, in their pharynx. As mentioned 
before, the importance of Waldeyer’s ring is that it constitutes the biggest reservoir 




NALT that acts in an analogous manner to the human tonsils in that it drives mucosal 
immunity via uptake and response to pathogen antigens, as well as has zones of B 
and T cells (Csencsits et al., 1999). NALTs of mice challenged with S. pyogenes 
were observed to manifest similar symptoms to the human tonsils, both triggering 
greater numbers of CD4+ T cells producing IFN-γ and IL-6, with human tonsils also 
producing IL-4 and IL-5 (Kerakawauchi et al., 1997, Park et al., 2004, Dileepan et 
al., 2011).  
 
Another limitation of this model is that pharyngeal infection in mice varies depending 
on mouse strain, age, sex, as well as inoculum volume, and S. pyogenes strain, 
which is why the Sriskandan lab published an optimised model assessing all 
aforementioned variables (Alam et al., 2013). This optimised variables are as 
follows: an inoculation volume of 5 μL of emm75 administered intranasally using a 
pipette, the use of FVB/n mice, and CFU enumeration coming from nares pressing 
on plates. Additionally, they found that S. pyogenes could persist longer in 5-week-
old mice, compared to 10-week-old, and that generally males could be colonised 






In the subcutaneous ulcer model, mice are usually inoculated with 106–108 CFU in 
the tissue, and lesions appear by 8-12 hours post infection (Watson et al., 2016). 
One of the biggest strengths of this model is that it reproduces many of the aspects 
of S. pyogenes disease, namely a highly inflammatory localised lesion in soft tissue 
with great levels of bacterial proliferation, and recruitment of large numbers of 
leukocytes. These recruited cells are primarily composed of neutrophils that 
surround the bacteria and create an abscess-like structure (Brenot et al., 2004). 
Studies have shown that macrophages are vital to the formation of this structure, 
which keeps the infection local and prevents dissemination, with one study reporting 
IL-12-driven interferon-gamma (IFN-γ) plays a key role (Raeder, et al., 2000, 
Mishalian et al., 2011).  
 
The surface area of the lesion, the time required to reach its maximum size, the time 
needed for the lesion to be resolved, and its formation or not, are all measurements 
used to assess virulence, for example between a mutant and its parent wild type 
(WT) strain (Watson et al., 2016). Other tests include lethality, weight monitoring, 
CFU recovery from the lesion, and for the S. pyogenes strains that disseminate and 
become systemic; CFU recovery from the spleen and inguinal lymph nodes. An 
example of such a strain that demonstrated enhanced virulence and a propensity to 
become systemic, is MGAS166, an emm1 clinical isolate, with mutations in its 
CovRS system (Engleberg et al., 2001). Several mouse strains have been used in 




SKH1 (Benavides et al., 2009). This mouse strain has a defect in its Hr gene, 
rendering it hairless. 
 
Limitations include the histopathology, despite what was mentioned above, not 
closely resembling human diseases, such as impetigo, probably due to differences 
in the mouse cutaneous tissue anatomy, such as higher density of hair follicles and 
a thin epidermal layer.  
 
Invasive Model 
Sepsis is relatively rare, and usually manifests as a complication of a soft tissue 
infection (Reglinski and Sriskandan, 2014, Wong and Stevens, 2013). There are 
several ways to reproduce the sepsis model in mice; an intravenous (IV), 
intraperitoneal (IP), intramuscular (IM), intranasal (IN), or intratracheal (IT) 
inoculation. A dose of 105-106 CFU is generally used, and many S. pyogenes strains 
have been reported to be used successfully (Watson et al., 2016). IV deposits S. 
pyogenes directly into the bloodstream, while the other models require S. pyogenes 
to invade deeper tissue, and subsequently to become systemic. When focusing on 
the systemic infection model, following initial infection of the upper respiratory tract, 
it has been proposed that IT inoculations, might be more useful as compared to IN. 
This is because hosts challenged with S. pyogenes IT, present symptoms much 
faster, and most of them manifest bacteraemia following those symptoms (Husmann 




counts from the spleen, liver, lungs, and blood. Humanised mice (hu-mice) have also 
been raised to address the human-specificity of S. pyogenes virulence factor targets. 
For example, a hu-mouse expressing human plasminogen was created to study 





Rodent infection models are still far from resembling a human infection as murine 
nasopharyngeal tissue architecture is not the same. For that reason, non-human 
primate models have been developed, such as the baboon, chimpanzee, 
cynomolgus macaque, and the rhesus monkey (Watson et al., 2016). Strengths of 
the primate models include close resemblance of immune system factors and 
responses to humans, easier access to the site of infection, a more expansive list of 
usable S. pyogenes strains, and an extended persistence of S. pyogenes at the site 
of infection. Limitations to these models include very high expense, low availability, 
and the fact that although few of them, like chimpanzees develop strong pharyngeal 
pathology, others like baboons, do not (Virtaneva, et al., 2003, Friou, 1950). 
 
In the baboon model, hosts are inoculated with 3 x 105 CFU of emm3 S. pyogenes 
by dribbling the inoculum over the posterior pharynx, which leads to S. pyogenes 
persistence for a minimum of six weeks (Ashbaugh et al., 2000). Acapsular or M-




weeks. Adding to this observation, another study showed that capsule production 
during the initial phases of pharyngeal colonisation (1 h post infection) was 
significantly upregulated, following delivery of S. pyogenes into the pharynx, using a 
moderately encapsulated emm3 isolate (Gryllos et al., 2001).  
 
Invasive Model 
A sepsis model of baboons has been established, with injection of 1010 CFU of an 
emm3 strain IV. Over the following 10 h, tests were carried out to analyse the 
progression of the infection, by the end of which mortality is close to 100% (Stevens 
et al., 1996). Those tests included body temperature, heart rate, arterial blood 








The complete analysis of the zebrafish (Danio rerio) genome, has revealed a high 
degree of both synteny with the human and similarities with the mammalian immune 
system (Postlethwait et al., 1999, Hsu, et al., 2004). Zebrafish have many orthologs 
of the human immune system, such as phagocytes, the complement system, 
cytokines, TLRs, and acquired immunity (Holland et al., 2002, Jault et al., 2004, 
Meijer et al., 2004, van der Vaart et al., 2012). All innate immune cells are present 
in zebrafish; macrophages, neutrophils, eosinophils, dendritic, and natural killer cells 
(Renshaw and Trede, 2012). Zebrafish macrophages and neutrophils have been 
reported to be morphologically and biochemically close to mammalian ones, with 
neutrophils being very unsuccessful at phagocytosing bacteria in fluid environments 
(Colucci-Guyon et al., 2011). The complement system also exists in zebrafish with 
orthologues of all its mammalian components. Acquired immunity wise, T cell 
receptor mRNA, secreted immunoglobulins, and T cell-dependent and -independent 
humoral responses also develop by 4 weeks post fertilisation (Lam et al., 2004). 
Zebrafish are inexpensive to maintain, and many available transgenic lines are 
commercially available (Nasevicius and Ekker, 2000). 
 
Zebrafish, both adult and larvae (embryo), have been already used for several 
pathogenesis studies. Burkholderia cenocepacia (Deng et al., 2009), 
Mycobacterium marinum (Prouty et al., 2003, Swaim et al., 2006), Staphylococcus 




Roca et al., 2008), and Streptococcus suis (Wu et al., 2008) are few of the pathogens 
that have been used in the zebrafish adult model. On the other hand, pathogens 
including Bacillus subtilis (Herbomel et al., 1999, Li et al., 2007), B. cenocepacia 
(Phennicie et al., 2010, Vergunst et al., 2010), Escherichia coli (Herbomel et al., 
1999, van der Sar et al., 2003), Haemophilus influenzae (Phennicie et al., 2010), M. 
marinum (Davis et al., 2002), Pseudomonas aeruginosa (Brannon et al., 2009, 
Clatworthy et al., 2009), S. aureus (Prajsnar et al., 2008), and Salmonella 
typhimurium (van der Sar et al., 2003, Li et al., 2007) have been used to challenge 
embryos. S. pyogenes has mainly been used to challenge adult zebrafish however, 
Lin et al used embryos to demonstrate that SLS prevents neutrophil recruitment at 
the initial stages of infection (Lin et al., 2009). In this study, 105 CFU of wild type and 
SLS- S. pyogenes were injected into the yolk sac of 1 dpf zebrafish to monitor 
survival, whereas 7 dpf fish were inoculated with 103 CFU to examine neutrophil 
recruitment. 
 
Adult Myonecrosis Model 
The adult zebrafish has been used to reproduce the myonecrosis model, with lack 
of immune cells being able to penetrate the lesion, large bacterial numbers at the 
site of infection, and big areas of necrotic tissue damage are all observed (Neely et 
al., 2002, Saralahti and Rämet, 2015). In the case of a strain switching from being 
resident to being systemic, CFU have been recovered from the spleen, but not from 
any other organs. Both intramuscular (IM) and intraperitoneal (IP) injections have 




3x104 for IM, but 2.5x102 CFU for IP (Rosch et al., 2008). By 24 hours post infection 
(hpi), a lesion forms at the site of infection, which expands until the host succumbs 
at 36 to 96 hpi. To investigate the virulence of mutants, a dose 10 or 100 times the 
LD50 is used. Virulence in this model is examined by survival rates, and CFU 
recovered (Phelps et al., 2009). The strains that have been used in this model are 
the extensively used emm14 type HSC5, and a the emm49 NZ131 (Neely et al., 
2003, Fisher et al., 2008). 
 
Zebrafish Embryos 
Zebrafish embryos can be an even stronger model for the following reasons. They 
can be easily genetically modified either by transiently knocking down genes via 
morpholino injections or by purchasing transgenic lines. Their small size also allows 
for large-scale screens. Another great advantage is the fact that the embryos grow 
ex utero and as a result, they can be used instead of adults in order to isolate and 
focus on the innate immune response. The zebrafish embryos are also transparent, 
allowing for fluorescent microscopy observations that allow for real-time 
pathogenesis studies of bacteria. However, one of the disadvantages of zebrafish is 
that the optimal temperature for the fish is 27-29 ºC, 6-10 ºC lower than the S. 
pyogenes natural host. At a temperature greater than 29 ºC, zebrafish viability 






A number of zebrafish embryo injection sites have been reported, including the axial 
vein near the blood islands, the yolk sac circulation valley, and the yolk sac/ball 
(Figure 1.8) (Prajsnar et al., 2008). One of the most common sites of infection, and 
the one used in this study, is the yolk sac circulation valley (Clatworthy et al., 2009). 
Embryos are anaesthetised using tricaine and are subsequently injected. Injections 
in the axial vein and the circulation valley deposit the inoculum directly into the 
bloodstream. Injections require a microinjector pump that deals minute amounts of 
air pressure, delivering volumes as low as 1 nL or less. The process also needs a 
manipulator to control the movement of the injection needle in a controlled fashion. 
Given the small size of both the embryos and needle, the experiments take place 
















Figure 1.8 Potential injection sites in zebrafish embryos  
The inoculum can be injected into, from left to right, the circulation valley, yolk, and axial 







Although, the mammalian models are biologically generally closer to humans, the 
logistics of maintaining these models along with the ethical issues have made 
alternative infection models more appealing. Invertebrate models have been widely 
used in infection studies as high-throughput screens for virulence (Sifri et al., 2003). 
Primarily due to ease of maintenance, low cost, high-throughput, amenable genetics 
etc. Caenorhabditis elegans has been used as a S. pyogenes infection model (Bolm 
et al., 2004, Jansen et al., 2002). Other reported invertebrate models for S. 
pyogenes are the silkworm Bombyx mori, and the waxworm Galleria mellonela 
(Kaito, et al., 2005, Loh, Adenwalla, Wiles, & Proft, 2013, Olsen, et al., 2010).  
 
1.7 Population dynamics 
 
There have been many studies analysing population dynamics during an infection 
(Grant et al., 2008, Prajsnar et al., 2012, Gerlini et al., 2014, Rego et al., 2014). 
Grant et al, used eight wild-type Salmonella enterica strains in a multi-organ study, 
and reported that soon after inoculation, bacterial phagocytosis and death, occurred 
with the subsequent replication of the survivors leading to independent 
subpopulations in different organs (Grant et al., 2008). A similar phenomenon was 
described by Gerlini et al where Streptococcus pneumoniae strains were used in 
mice in order to study bacteraemia. Collection and analysis of blood samples, 




events (Gerlini et al., 2014). This suggested a single bacterial cell bottleneck as the 
potentiator of disease. In a S. aureus study by Prajsnar et al, it was demonstrated 
that professional phagocytes drive the pathogen through a very narrow population 
bottleneck that results in only a few bacteria escaping this control (Prajsnar et al., 
2012). These survivors go on to form lesions and overwhelm the host. Additional 
population dynamics studies also exist with Salmonella typhimurium (Maier et al., 
2014. Lim et al., 2014) as well as Borrelia species (Rego et al., 2014). All these 
reports collectively describe the population pressure effect (bottleneck), exerted on 
the pathogens, by the host immune defences. However, it seems that not all 
bottlenecks are as narrow as in S. aureus, as different pathogens interact with the 
host in different ways. 
 
1.8 Exploring the effect of commensals in S. pyogenes infection 
 
How hosts get infected with opportunistic pathogens, such as S. pyogenes, is an 
interesting and open question. These organisms live within a polymicrobial milieu 
from which they emerge to cause an infection, given the appropriate opportunity. 
This is often presented as a breach in innate defences, such as a wound. In such 
cases, the initial infectious dose is likely to be low, and in the presence of a range of 
other microbes and material.  For example, the lungs of a Cystic Fibrosis patient can 
be co-infected by both S. aureus with Pseudomonas aeruginosa (Mashburn et al., 
2005). This is true for S. pyogenes. In the context of the skin, an injury that leads to 




Although, commensals can confer additional protection against invading pathogens 
by creating a very competitive environment to colonise, they have been also shown 
to potentiate an infection. It was also reported that Staphylococcus epidermidis 
releases anti-inflammatory cytokines that neutralise monocyte pro-inflammatory 
cytokines (Laborel-Préneron et al., 2015). As this action of the monocytes is in 
response to S. aureus, S. epidermidis effectively dampens the host response. 
Furthermore, a phenomenon called augmentation, was described, in which the 
presence of a commensal organisms, or their cell wall peptidoglycan, results in 
enhanced virulence of S. aureus during infection in both zebrafish embryos and mice 
(Boldock et al., 2018). 
 
The Augmentation Effect 
Boldock et al, initially showed in 1 dpf zebrafish embryos that although a low dose 
of 150 CFU of S. aureus yielded about 90% survival, co-infection of this S. aureus 
dose with 2000 CFU of M. luteus, results in a significant decrease of survival down 
to 50% (Boldock et al., 2018). 50% host survival was noted at the S. aureus high 
dose of 1500 CFU, which shows that augmentation allows for a 10-fold decrease in 
the infectious dose. This is despite the fact that 2000 M. luteus alone does not cause 
any mortality. This augmentation effect was also observed when using a S. aureus 
virulence attenuated mutant (pheP saeR) instead of M. luteus. Albeit, M. luteus 
being cleared from the host, is still leads to an enhanced S. aureus virulence 
measured by host mortality and pathogen proliferation. S. aureus and M. luteus were 





This phenomenon was subsequently tested and also seen in mice, where co-
injecting 108 CFU of Staphylococcus epidermidis or M. luteus with the low dose of 
S. aureus (105 CFU), resulted in reduced mouse weight and increased S. aureus 
numbers in the liver. In mice, the infectious dose could be reduced by 1000-fold 
when mixing with an augmenting organism. Following experiments interrogated the 
molecular basis of augmentation. Heat-killed M. luteus was able to augment S. 
aureus virulence in zebrafish, hence the presence of a bacterial cellular component 
was hypothesised to be key for this mechanism. It was reported that infection could 
be augmented using insoluble cell wall peptidoglycan from M. luteus, S. epidermidis, 
Bacillus subtilis, Curtobacterium flaccumfaciens, and S. aureus. This suggest that 
there must be a conserved moiety driving this phenomenon.  
 
Non-pathogen Interactions with the Immune System: Live Commensals 
There have been numerous studies reporting that bacteria, other than the pathogen 
in question, can interact directly with either the host immune system or the pathogen 
itself. This has ramifications to the efficacy of the pathogen. For instance, although 
S. epidermidis has been known to be a relatively mild pathogen, Vandecandelaere 
et al., demonstrated that its serine proteases could break down S. aureus biofilms, 
leading to increased survival of C. elegans (Vandecandelaere et al., 2014). The 
same avirulent bacterium, was reported to restrict Candida albicans invasion via 





On the contrary, the presence of M. luteus present at the time of infection with S. 
aureus, was reported to yield an increased level of host mortality. This allowed for 
the infectious dose of S. aureus to be decreased 10-fold in zebrafish, and 1000-fold 
in mice in the respective systemic models. (Boldock et al., 2018).  
 
Non-pathogen Interactions with the Immune System: Adjuvants 
The aforementioned augmentation effect, that occurred by co-injecting S. aureus 
with the skin commensal M. luteus, was also observed when S. aureus was mixed 
with purified M. luteus or S. aureus peptidoglycan instead. This increased killing 
allowed the infective dose, in the mouse sepsis model, to significantly drop from 107 
to 104 CFU, thanks to the added peptidoglycan.  
Furthermore, a few other studies have described similar effects, where for instance 
different prospective adjuvants like starch were tested (James and MacLeod, 1961). 
Starch, being found in surgical glove powder and suture materials, was stated to 
have an augmenting effect to an S. aureus wound infection. This led to the dose to 
be lowered from 107 to 103. Another study indicated that depending on the timing of 
injection of E. coli, it can confer protection against infection or increased 




1.9 Aims of the project 
 
The primary aim of this project was to establish the S. pyogenes infection model in 
the zebrafish embryo (larvae). The next step was to use established tools, such as 
morpholino genetic manipulation and fluorescence microscopy, to interrogate the 
validity of this model, and whether it resembles appropriate host-pathogen 






Chapter 2: Materials and Methods 
 
2.1 Bacterial media 
 
Bacterial media were all prepared using distilled water (dH2O), and were sterilised 
by autoclaving for 20 minutes at 121 °C and 15 psi. 
 
2.1.1 Todd-Hewitt 0.2% w/v yeast (THY) broth 
 
Todd-Hewitt Broth (Oxoid)    36.4 g L-1 
Yeast extract (Oxoid)                        2.0 g L-1 
 
THY agar contained 0.7% Oxoid No.1 agar. 
 
2.1.2 Columbia horse Blood Agar (CBA) 
 
Special peptone  23.0 g L-1 
Starch    1.0   g L-1 
Sodium chloride  5.0   g L-1 
Agar    10.0 g L-1 
pH 7.3 ± 0.2 at 25 °C 
 





2.1.3 Luria-Bertani (LB) broth 
 
Tryptone (Oxoid)    10 g L-1 
Yeast extract (Oxoid)     5 g L-1 
NaCl        5 g L-1 
 
1.5% (w/v) Oxoid No. 1 agar was added to make LB agar. 
This media was used for cultivating E. coli. 
 
2.1.4 Brain Heart Infusion (BHI) broth 
 
Brain Heart Infusion (Oxoid)  37 g L-1 
1.5% (w/v) Oxoid No. 1 agar was used for BHI agar. 
 
2.1.5 Electroporation medium 
 
MgCl2    1 mM pH 6.5 







Tetracycline (Tet) was used in this study. The S. pyogenes working concentration 
was 5 μg mL-1. The antibiotic stock solutions were prepared by dissolving the 
antibiotics in appropriate solvent, filter-sterilised (0.22 μm pore size) and stored at -
20 °C. For use in agar plates, the antibiotic stock solutions were added to the media 
once they had cooled to below 55 °C. For use in liquid media, the antibiotic stock 
solutions were added prior to usage. 
 
2.3 Bacterial strains 
 
2.3.1 Streptococcus pyogenes strains 
 
The S. pyogenes strains used in this study are listed in Table 2.1. Strains were grown 
from -80 °C Microbank beads (Pro Lab Diagnostics) and cultured onto CBA plates 
with antibiotics incorporated if necessary, to maintain resistance markers. For short-
term storage, strains were kept on CBA plates at 4 °C. For long-term storage, a 
single colony was mixed with Microbank bead stocks and kept at -80 °C. 
 
For bacterial growth in liquid media, strains were grown at 5% v/v CO2 at 37 °C. 
Three colonies were used to inoculate 10 mL THY broth, in a 15 mL tube, and 




with the necessary volume so the OD600 was close to 0.05, and re-incubated at 37 
°C at 5% v/v CO2 until 0.3 OD600. 
 
Table 2.1 List of S. pyogenes strains used in this study 
Strain Genotype or description Reference 
H305 emm1 type (Sriskandan et al., 2002) 
HSC5 emm14 type 
(Port et al., 2013) 
H293 emm89 type (Turner et al., 2015) 
H293-GFP H293 carrying pMV158-gfp, TetR This study 
H293-mCherry H293 carrying pMV158-mCherry, TetR This study 
 
TetR – tetracycline resistant 
 
2.3.2 Escherichia coli strains  
 
E. coli strain TOP10 from Invitrogen was used in this study. Strains were grown 
from -80 °C Microbank beads (Pro Lab Diagnostics) and cultured onto LB agar 
plates. For short-term storage, strains were kept on LB agar plates at 4 °C. For long-
term storage, a single colony was inoculated into Microbank bead stocks and kept 





For bacterial growth in liquid media, strains were grown aerobically at 37 °C. Three 
colonies were used to inoculate 5 mL LB and incubated overnight at 37 °C on a 
rotary shaker at 250 rpm. 0.5 mL of overnight culture was used to inoculate 50 mL 
LB in a 250 mL conical flask and re-incubated at 37 °C and 250 rpm on a rotary 
shaker until exponential phase growth was reached. 
 
2.3.3 Staphylococcus aureus strains  
 
Strain SH1000 was used in order to retrieve the pMV158-gfp and pMV158-mCherry 
plasmids (Prajsnar et al., 2008). Growth and storage methods were the same as for 
E. coli but using BHI. 
 
2.3.4 Micrococcus luteus strains 
 
M. luteus SJF256 (ATCC4698, Sigma Lysophilised cells) was used in this study. For 
this study, frozen inocula prepared and provided by Dr Josie Gibson (University of 
Sheffield) were used. They were grown aerobically at 30 °C in BHI, and stored 




Plasmids used in this study were the pMV158 ones carrying gfp and mCherry (Nieto 
and Espinosa, 2003). All plasmids were purified from S. aureus SH1000 strains 




2.5 Buffers and solutions 
 
All buffers and solutions were prepared using dH2O, sterilised by autoclaving, if 
necessary, and stored at room temperature. 
 
2.5.1 Phosphate buffered saline (PBS) 
 
NaCl   8.0 g L-1 
Na2HPO4  1.4 g L-1 
KCl   0.2 g L-1 
KH2PO4  0.2 g L-1 
 
2.5.2 QIAGEN buffers 
 
2.5.2.1 QIAGEN Buffer P1 
 
Tris-HCl, pH 8.0     50 mM 
EDTA      10 mM 
RNase A    100 μg mL-1 
 
2.5.2.2 QIAGEN Buffer P2 
 
NaOH    200 mM 




2.5.2.3 QIAGEN Buffer P3 
 
Potassium acetate, pH 5.5   3.0 M 
 
2.5.2.4 QIAGEN Buffer EB 
 
Tris-HCl, pH 8.5    10 mM 
 
2.5.2.5 QIAGEN Buffer TE 
 
Tris-HCl, pH 8.0    10 mM 
EDTA       1 mM 
 
2.5.2.6 QIAGEN Buffer QBT 
 
NaCl      750 mM 
MOPS       50 mM, adjusted to pH 7.0 with NaOH 
Isopropanol       15% (v/v) 





2.5.2.7 QIAGEN Buffer QC 
 
NaCl        1 M 
MOPS     50 mM, adjusted to pH 7.0 with NaOH 
Isopropanol     15% (v/v) 
 
2.5.2.8 QIAGEN Buffer QF 
 
NaCl      1.25 M 
Tris-HCl pH 8.5    50 mM 
Isopropanol     15% (v/v) 
 
2.5.2.9 QIAGEN Buffer N3, PB, PE 
 





2.6 Chemical dyes 
 
All dyes were purchased from Fisher Scientific. 
 
Table 2.2 Chemical dyes used in this study 
Stock solution Stock concentration Solvent Storage 
AlexaFluor405 10 mM DMSO -20 °C in dark 
AlexaFluor647 10 mM DMSO -20 °C in dark 
pHrodo Red 10 mM DMSO -20 °C in dark 
 
2.7 Determination of bacterial cell density 
 
2.7.1 Spectrophotometric measurement (OD600) 
 
To quantify the bacterial yield of a liquid culture, spectrophotometric measurements 
at 600 nm (OD600), were carried out. These measurements were taken using a 
Jenway 6100 spectrophotometer. At OD600 over 1, samples were diluted 1:10 in the 
appropriate sterile culture medium. 
 
2.7.2 Cell counts (CFU mL-1) 
 
To determine viable cell numbers, cell counts were performed. Bacterial samples 
were serially diluted 1:10 in THY and plated in triplicates or quadruplicates. 10 μL 




antibiotics where appropriate. After overnight incubation at 37 °C, and at 5% v/v 
CO2, the number of colony forming units (CFU) was determined. 
 
2.8 DNA Purification techniques 
 
2.8.1 Plasmid preparation from S. aureus 
 
Plasmid purification from S. aureus was performed using the QIAGEN QIAprep™ 
Spin column kit. A 3 mL overnight culture of S. aureus was first mixed and incubated 
with 10 μL of lysostaphin (Sigma-Aldrich). This digests the cell wall which exposes 
the plasmids for purification. The cell content was then recovered by centrifugation 
in a microcentrifuge at 10,000 rpm for 1 min. The pellet was then resuspended in 
250 μL of buffer P1 with RNase A. For lysis, 250 μL buffer P2 were added and the 
1.5 mL Eppendorf tube was gently inverted 10 times; the lysis reaction was not 
allowed to proceed for more than 5 min. 350 μL of neutralising buffer N3 was added 
and the tube immediately inverted gently 10 times to prevent localised precipitation. 
The cloudy suspension was then centrifuged for 10 min at 13,000 rpm to remove 
precipitated proteins, chromosomal DNA, cellular debris and SDS. The supernatant 
was transferred into a QIAprep spin column and centrifuged for 1 min at 13,000 rpm. 
The flow-through was discarded. The column was washed with 750 μL of buffer PE 
and centrifuged for 1 min at 13,000 rpm. To remove residual wash buffer that may 
inhibit further reactions, the flow-through was discarded and the tube centrifuged 




the DNA eluted by pipetting 50 μL of dH2O directly to the centre of the column. The 
column was left to stand for 1 min before centrifugation at 13,000 rpm for 1 min. The 
eluted plasmid DNA was stored at -20 °C. 
 
2.9 Transformation of S. pyogenes 
 
2.9.1 Preparing electro-competent S. pyogenes cells 
 
10 mL of a S. pyogenes overnight culture was used to inoculate 90 mL of preheated 
THY. The solution was left to incubate with 30 μL of hyaluronidase (30 μg/mL) for at 
least 30 min. At an OD600 of 0.150 - 0.175, the culture was centrifuged at 4500 rpm 
at 4 °C for 10 min. The supernatant was discarded, and the cells were washed twice 
with ice-cold electroporation medium at 4500 rpm at 4 °C. After the last wash, the 
cells were resuspended in 750 μL of electroporation medium, kept on ice, and used 
for transformations immediately. 
 
2.9.2 Electroporation of DNA into competent S. pyogenes cells 
 
A mixture of 75 μL of competent cells with 5 μL of DNA was placed within 1.5 mL 
Eppendorf tubes. At least 0.1 μg of purified plasmid was used. This solution was 
then transferred into sterile electroporation cuvettes (1 mm).  
 
Electroporation was conducted with a Gene Pulser system set at 1 kV, 129 Ω, and 




entire suspension was placed in a 15 mL tube with 9 mL of preheated THY. The 
tubes were left to incubate at 37 °C for 2.5 - 3 hours. The cells were then harvested 
by centrifuging at 2000 rpm for 10 min, and plated onto CBA or THY-tet plates.  
 
2.10 Zebrafish lines 
 
The London Wild Type (LWT) zebrafish line was used for most of the experiments 
involving zebrafish. For microscopy experiments, the following lines were used: 
 
Table 2.3 Transgenic zebrafish lines used in this study 
Name Features Reference 
Tg(mpeg1:mCherry-CAAX)sh378 mCherry macrophages (Loynes et al., 2018) 




(Prajsnar et al., 2012) 
Tg(lyz:nfsB-mCherry)sh260 NTR neutrophils, for Mtz  (Buchan et al., 2018) 
 
2.11 Zebrafish husbandry 
 
Adult zebrafish were housed in a continuous re-circulating closed aquarium system 
with light day/night cycle of 14/10 hours, respectively, at 28 °C. All embryos collected 
were kept in E3 1x medium at 28.5 °C. 
 
Transgenic adult fish were handled under a Project Licence awarded by the UK 




out using younger than 5 dpf embryos, hence not protected under the Animals 
(Scientific Procedures) Act. 
 
2.12 Zebrafish media 
 
2.12.1 E3 (x10) 
 
NaCl     50 mM 
KCl    1.7 mM 
CaCl2    3.3 mM 
MgSO4   3.3 mM 
 
A 1x solution was used for experiments which was derived from a 10x stock in 
distilled water. Methylene blue was also added (approximately 5x10-5 % final 
concentration) for fungal growth prevention (Nusslein-Volhard C, 2002), and 
autoclaved. 
 
2.12.2 Methylcellulose  
 
Methylcellulose was prepared at a 3.0% (w/v) concentration in E3. As solubilisation 
is critical, it was partially frozen, mixed and defrosted several times (Nusslein-
Volhard and Dahm, 2002). The resulting solution was subsequently aliquoted into 
20 mL syringes and frozen for long-term storage. Syringes were also kept at 28.5 




2.13 Zebrafish anaesthesia 
 
A stock solution of 0.4% (w/v) 3-amino benzoic acid ester (tricaine or MS322, Sigma) 
was prepared in 20mM Tris-HCl (pH adjusted to 7) and stored at -20 °C. A working 
stock was kept at 4 °C in the dark. Before any injections or microscopy experiments 
were carried out, embryos were anaesthetised in a 0.02% (w/v) tricaine. 
 
2.14 Microinjections of S. pyogenes into zebrafish embryos 
 
A 50 mL tube, with 50 mL prewarmed THY, was inoculated from an overnight culture 
of S. pyogenes. Following that, 40 mL were collected to adjust for the same OD600 
as well as to make up for any volume discrepancies due to additional OD600 
measurements of any specific culture. These 40 mL were grown until the OD600 was 
approximately 0.3, and the cells were harvested by centrifugation (4500x g, 10 min, 
4 °C). The cells were resuspended in fresh THY media to the set concentration for 
the experiment, and kept on ice throughout the injections. The volume of fresh 
THY added, was appropriate for each experiment and strain, and doses were 
quantified before and after injections. This was done by a 10-4 dilution of the dose in 
sterile THY, and 4 spots of 10 μL, were plated on CBA plates, and incubated at 37 
°C at 5% v/v CO2 overnight. The CFUs were counted the next day. M. luteus frozen 
aliquots were provided by Dr Josie Gibson, were thawed, washed once with PBS, 





The larvae were naturally dechorionated, as they were at 2 dpf, and injected with 1 
nL of the bacterial suspension, after being anaesthetised and immobilised onto 3.0% 
(w/v) methylcellulose. An electrode puller was used to create a fine injection tip on 
non-filament glass capillaries, in which the bacteria were then loaded. The injection 
volume was calibrated with the use of a graticule slide. For injections, a pneumatic 
micropump (WPI, PV820), a micromanipulator (WPI), and a dissecting light 
microscope (Leica) were used. 
 
Following injections, embryos were incubated in Petri dishes with E3 at 28.5 °C for 
about 1 hour, allowing for the methylcellulose to dissolve. The fish were then 
transferred individually into 96-well plates. 
 
2.15 Determination of zebrafish embryo mortality following infection 
 
Fish groups of 25-30 embryos were injected with S. pyogenes. Post injections, the 
embryos were visually inspected, using a dissecting light microscope (Leica), once 
a day. Heartbeat cessation was used as evidence of mortality. 
 
2.16 Determination of S. pyogenes growth in vivo 
 
In order to measure S. pyogenes in vivo growth, the appropriate number of fish were 
individually collected at each time-point, and placed into ceramic bead-containing 2 
mL cap containers (Peqlab) with 200 μL of E3. The embryos were then mechanically 




THY, plated onto CBA plates or Omni trays, and left at 37 °C overnight. The CFUs 
were determined the next day. 
 
2.17 Fixation of embryos 
 
For fixing embryos, Paraformaldehyde 4% (w/v) (PFA) dissolved in PBS, was used. 
Embryos were anaesthetised and transferred into ice-cold PFA, and left to incubate 




2.18.1 Mounting of zebrafish 
 
Embryos were anaesthetised, and placed on a coverslip (number 0) mounted over 
a 10 mm puncture in a 50 mm plastic Petri dish. They were then immersed in a 1% 
(w/v) low melting point agarose (Sigma) E3 solution, and left for about 8 min, until 
the agarose solidified. 
 
2.18.2 Imaging of zebrafish 
 
In this study, the following three microscopes were used: 
 
1. UltraVIEW VoX (Perkin Elmer): This spinning disc confocal microscope was 




mCherry, AlexaFluor647, and AlexaFluor405 were excited by a 457-514 nm 
argon laser, a 561 nm sapphire laser, a 642 nm diode laser, and a 407 nm 
laser. Images were acquired using its bright field, GFP, TxRed, and far red 
emission settings using a Hamamatsu C9100-50 EM-CCD camera. Volocity 
software was used for image acquisition and processing. The 4x Nikon Plan 
Fluor NA 0.13, and the 20x Nikon Plan Fluor NA 0.45 objectives were used. 
GFP was excited with 488 nm. 
 
2. Nikon TE-2000 U: This microscope uses a Hamamatsu Orca-AG camera, 
and NIS Elements for both image acquisition and processing.  
 
3. Nikon custom widefield: This microscope was used for the strain population 
dynamics experiments of Chapter 5. The objective used was 10x NA 0.45. NIS 
Elements was used for both image acquisition and processing. 
Its features include: a Nikon Ti-E, a CFI Plan Apochromat λ, a custom-built 
500 μm Piezo Z-stage, and ET/sputtered series fluorescent filters 49002 and 
49008. 
 
2.19 Chemical staining of S. pyogenes 
 
The same protocol was followed for pHrodo and AlexaFluor405 staining of S. 
pyogenes, as well as for AlexaFluor647 labelling of peptidoglycan (PG). For PG, 
frozen aliquots were resuspended, and directly mixed with the dye. Bacteria were 




was instead carried out in PBS pH9, and not THY. 200 μL of that culture was 
subsequently mixed with 0.5 μL of 2.5 mM pHrodo. This mixture was left to incubate 
for 30 min on a 100 rpm rotary shaker at 37 °C. To remove excess dye, three washes 
followed. The tube was taken from the shaker, and 1 mL PBS pH 8 was added to it, 
it was vortexed, and centrifuged (13,400 rpm, 3 min, RT). Two more washes followed 
with 1 mL 25 mM Tris pH 8.5, and 1 mL PBS pH 8, respectively. After the final 
supernatant was removed, S. pyogenes was resuspended in 200 μl of PBS pH 7.4, 
and kept on ice.  
 




Morpholino-modified antisense oligonucleotides were acquired from Gene Tools, 
LLC. In this study, morpholinos targeted the mRNA AUG codon in order to knock-
down the translation of the gene of interest, and were used at a concentration of 0.5 
pmole per embryo. 
 
Table 2.4 Morpholinos used in this study 
MO target Sequence (5’ - 3’) Reference 
pu.1 GATATACTGATACTCCATTGGTGGT (Rhodes et al., 2005) 
irf8 TCAGTCTGCGACCGCCCGAGTTCAT (Li et al., 2011) 





2.20.2 Morpholino injections into zebrafish eggs 
 
Morpholinos were kept in 2 mM stocks in dH2O, but injected at 1 mM into the yolk 
sac of 1-4 cell embryos as described in 2.14. 
 
2.21 Neutrophil ablation via Metronidazole treatment  
 
Tg(lyz:nfsB-mCherry)sh260 embryos carrying NTR-expressing neutrophils were 
collected (Table 2.3). At 34 hpf, the larvae were treated with 10 mM dissolved in E3 
for 18 h. The plates were additionally wrapped loosely with foil to protect Mtz from 
light. The embryos were inoculated with S. pyogenes at 54 hpf. 
 
2.22 Macrophage ablation via Metronidazole treatment  
 
LWT embryos were mechanically dechorionated at 24 hpf, and subsequently 
injected with liposome-encapsulated clodronate or liposome-encapsulated PBS as 
the control. The fish were left to incubate overnight, and they were injected with S. 





2.22 Statistical analysis 
 
All statistical analysis was performed in GraphPad Prism version 7.04. Zebrafish 
groups had always n=25-30. A representative graph is shown from three replicates 
of each experiment. Zebrafish data was not combined as embryo batches vary. 
 
Survival analysis: Comparisons between survival curves of different groups were 
assessed using the log-rank Mantel-Cox test. 
 
Linear regression: Line of best fit for all data points within an experiment. R2=1 










3.1.1 Choosing an embryo age 
 
For my infection study, 1-day post fertilisation (dpf) or 2 dpf zebrafish embryos were 
explored. The first model has been widely used before for infection studies, while 
the latter allows for a more robust immune system (Prajsnar et al., 2008). Both ages 
are at a developmental stage that enables the isolation and the investigation of the 
innate immune system without any complications from the adaptive immune system, 
that becomes functional 4-6 weeks later (Sullivan et al., 2017). At 2 dpf, fish have 
both mature macrophages and neutrophils, as functional macrophages have been 
detected at about 1 dpf (Herbomel et al., 1999), and mature neutrophils emerge at 
2 dpf (Lieschke et al., 2001). Exploring host-pathogen interactions between S. 
pyogenes and zebrafish is the aim of this study. Hence, to that end, this chapter 
sought to establish the model that was subsequently used as a platform to ask the 
questions of the next two following chapters. Technically, at roughly 2 dpf, the fish 
are called pro-larvae, however, going forward they will be called “embryos”. Finally, 
after injections, the embryos are monitored only until they become protected under 





3.1.2 Choosing an S. pyogenes strain 
 
HSC5 (emm14) 
The HSC5 strain is an emm14 type that has been the preferred strain for the few 
adult zebrafish models that have been developed, and the only one of the three 
strains in this study that has been used in zebrafish (Neely et al., 2003, Fisher et al., 
2008). The origin of this strain is not known. It is an encapsulated strain that has 
been reported to have a strong production of the SpeB cysteine protease, but no 
NAD-glycohydrolase activity (Meehl et al., 2005). 
 
H293 (emm89) 
H293 (emm89, PT4245 type- Central Public Health Laboratory of London) was 
acquired from thigh muscle tissue of a patient who survived necrotizing fasciitis and 
STSS (Sriskandan et al., 2000, Turner et al., 2009, Turner et al., 2015, Reglinski et 
al., 2016). This emm89 strain has high expression levels of SpeB, a cysteine 
proteinase that contributes to evasion of the immune system. Additionally, it is 





H293 has been fully genome sequenced and annotated (GenBank accession no. 
HG316453.2), and is genetically transformable (personal communication with Dr 
Claire Turner, University of Sheffield). Finally, it is well-characterised both in vitro 
and in vivo (Sriskandan et al., 2000, Turner et al., 2012, Reglinski et al., 2015, Lamb 
et al., 2018). 
 
H305 (emm1) 
H305 is an emm1 strain (NCTC 8198) that was isolated from the throat of a patient 
with scarlet fever (Reglinski et al., 2015, Reglinski et al., 2016). emm1 is the single 
most prevalent type that has dominated Europe, the US and Canada (Gherardi et 
al., 2018).  H305 produces SpeB at high levels (Unnikrishnan et al., 1999). This 
strain also carries a single-base insertion mutation in covS that truncates the protein 
and disrupts the CovR/S regulon  (Turner et al., 2009). H305 is additionally well-
characterised in murine models (Alam et al., 2013). 
 
3.2 Aims of this chapter 
 
i. To establish a systemic model of infection in zebrafish embryos. 








3.3.1 Determination of optimal infection point post-fertilisation 
 
The first question to be addressed was whether injection of 1 dpf (30 hours post 
fertilisation- hpf) embryos is suitable to establish the S. pyogenes infection model. 
This model has been used for several other pathogens, such as Staphylococcus 
aureus (Prajsnar et al, 2008). In the case of 1 dpf embryos proving too susceptible 
to S. pyogenes to study, 2 dpf (54 hpf) fish were also used as they have a more 
robust immune system. Hence, in order to determine the optimal infection point post-
fertilisation, a pilot study was run comprised of four dose titration experiments. 
 
Two dose titration experiments were carried out using 1 dpf embryos (Figure 3.1). 
The experiments were carried out by injecting into the bloodstream via the ventral 
aspect of the yolk sac circulation valley of the embryos. They were then placed into 
individual wells of a 96-well plate and monitored at 28.5 ºC for 3 days. The first strain 
to be examined was the emm14 type HSC5 as it has been studied in zebrafish in 
the past (Miller and Neely, 2004, Neely et al., 2002), with the second one being a 
more clinically relevant one; the emm89 type H293. Using HSC5 (emm14), a dose 
as low as 50 CFU caused 6% survival as early as 24 hours post infection (hpi), which 
remained the same until 66 hpi (Figure 3.1A). On the other hand, H293 (emm89) 
was not as virulent with the lower doses 34 and 103 CFU yielding 81% and 88% 




survival (Figure 3.1B). Due to the high mortality caused by HSC5, the 2 dpf model 
was also tested.  
 
The two S. pyogenes strains were tested in 2 dpf embryos to assess pathogenesis. 
For both strains, embryo survival demonstrated a dose-dependent increase in 
mortality. HSC5 was observed to be still more virulent than H293. In this model, an 
HCS5 dose of 57 CFU yielded a 67% survival by 66 hpi, whereas a dose of 1413 
CFU gave 0% survival (Figure 3.1C). In the case of H293, the low dose of 253 CFU 
caused 73% survival by 66 hpi (Figure 3.1D). These pilot experiments demonstrated 
that using the 2 dpf model, infection could be monitored in a timescale amenable to 
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Figure 3.1 Effect of embryo age on the S. pyogenes zebrafish infection model  
Survival of 1 dpf (A,C) and 2 dpf (B,D) embryos injected with S. pyogenes HSC5 and H293 
with doses as indicated. For each group n= 25-30. Negative controls shown here were taken 
from another experiment and were performed using PBS (n=10). S. pyogenes supernatant 
was also tested, and no mortality was observed (data not shown). (B) p= 0.0089 (**), p= 
0.0028 (**), p<0.0001, (C) p=0.0009(***), p=0.0003 (***), (D) p= 0.0304 (*), p<0.0001 (****).    




3.3.2 Investigation of HSC5 virulence in the zebrafish embryo model 
 
The zebrafish embryo infection model was then further characterised using strain 
HSC5. Dose titration experiments were performed in order to characterise the 
parameters of the model. Independent dose titration experiments were performed, 
and a representative of three is shown in Figure 3.2A. The three groups in Figure 
3.2A show a dose-dependent survival with 57 CFU yielding about 70% survival, 429 
CFU 36%, and 1413 CFU 6%. Linear regression further confirmed this dose 
dependency (Figure 3.2B).  
 
3.3.3 HSC5 population dynamics in vivo  
 
In this experiment, 40 CFU yielded approximately 50% survival (Figure 3.2C). No 
host death was noted until 17 hpi, after which additional mortality was only seen up 
to 43 hpi (Figure 3.2D). For each time-point, 5 live and all succumbed larvae were 
collected, homogenised, and plated on media. Bacterial numbers had already begun 
increasing by as early as 2 hpi (Figure 3.2D). At 8 hpi, the data suggests a bifurcation 
of populations, one population having high bacterial numbers of 104-105 CFU, and 
the other population low bacterial numbers of undetectable to 102 CFU. At 17 hpi, 
the first mortality was noted, with overwhelmed hosts revealing >104 CFU. Despite 
few live fish after 17 hpi having <102 CFU, there were a few live embryos carrying 
>105 CFU. Figure 3.2D demonstrates that that HSC5 virulence is associated with 




















Figure 3.2 Host-pathogen dynamics during zebrafish embryo infection with HSC5  
A,B) LWT larvae were inoculated with HSC5 S. pyogenes with doses as indicated (n=25-
30) (A). p= 0.0089 (**), p= 0.0028 (**), p<0.0001 (****).  All dose titration experiments (n=9) 
at 66 hpf were combined into one figure, and a linear regression line was drawn (B). 
C,D) In vivo growth of S. pyogenes HSC5 in zebrafish embryos. Fish were injected with 40 
CFU. At each time point, 3-5 live embryos and all dead ones were collected, homogenised, 
and 100 μL were plated on THY plates. Live embryos are marked with open circles, and 







3.3.4 Investigation of H293 virulence in the zebrafish embryo model 
 
The same protocol was followed to carry out dose titrations with the H293 emm89 
strain. Three independent experiments were run, a representative of which is 
presented in Figure 3.3A. The model shows a clear dose dependence between 250 
to 4000 CFU inoculum. Linear regression supported this assertion (Figure 3.3B). 
Approximately 1800 CFU gave a dose of 50% embryo survival after 66 hpi. This 
provided a convenient dose for future experiments.  
 
3.3.5 H293 population dynamics in vivo  
 
Using the dosing experiment as a guide, embryos were injected with 1400 CFU 
H293 at 54 hpf. This led to approximately 50% embryo survival after 66 hpi (Figure 
3.3C). No hosts had succumbed until 21 hpi, and of those embryos that did, most 
had done so by 44 hpi. 5 live embryos and all dead ones were collected at each 
time-point, homogenised, and evaluated for total CFU. After injection, bacterial 
numbers began to alter within individual embryos. After 10 hpi, succumbed embryos 
begun to appear. All overwhelmed hosts had a bacterial load of >105 CFU, whereas 
this was never observed in live hosts.  In fact, all live larvae showed a reduction in 
bacterial numbers from the original dose injected, often to the limit of detection. 
These results confirm that H293 virulence is linked to bacterial growth, and although 
bacterial proliferation is restricted for about 8 hours, in some fish, S. pyogenes can 
then grow and overwhelm the host. This shows that this chosen infectious dose 




















Figure 3.3 Host-pathogen dynamics during zebrafish embryo infection with H293 
A,B) Survival of 2 dpf LWT fish injected with H293 S. pyogenes with doses as shown (n=25-
30) (A). p= 0.0304 (*), p<0.0001 (****).  All dose titration experiments (13) at 66 hpf were 
combined into one figure, and a linear regression line was drawn (B). 
C,D) In vivo growth of S. pyogenes H293 in zebrafish embryos. The infectious dose was 
1400 CFU. At each time point, 5-6 live embryos and all dead ones were collected, 
homogenised, and 10 μL were plated on THY omni trays. Live embryos are marked with 






3.3.6 Investigation of H305 virulence in the zebrafish embryo model  
 
The last S. pyogenes strain to be examined was H305. This emm1 type, displayed 
the highest virulence with 91 CFU producing 28.5% host survival, 858 CFU 15%, 
and 1888 CFU 5% (Figure 3.4A). This figure is a representative of three independent 
experiments, each group having n=25-30. The linear regression line in Figure 3.4B 
illustrates both a dose-dependency and the very high virulence of H305 compared 
to the other two strains used here.  
 
3.3.7 H305 population dynamics in vivo 
 
An infectious dose of 28 CFU resulted in about 50% survival. 5 live zebrafish 
embryos were then collected along any embryos that had succumbed at every time-
point, homogenised, and examined for their bacterial load. Similar to the other two 
strains, no fish had succumbed up until 17 hpi, when the first mortality was seen 
(Figure 3.4D). The two distinct populations were very apparent in the case of this 
strain. S. pyogenes started growing by the first time-point at 2 hpi and can be seen 
growing steadily between 2-8 hpi with CFU numbers being between ~102 and 104. 
Between those two time-points a second population of hosts was noted, that was 
able to successfully restrict S. pyogenes, with CFU numbers remaining <102 with 
few live embryos going up to <103 at 66 hpi. The first fish that succumbed at 19 hpi, 
carried 106, with all of the subsequent overwhelmed hosts having 106-107 CFUs. In 




















Figure 3.4 Host-pathogen dynamics during zebrafish embryo infection with H305  
A,B) Survival of 2 dpf LWT larvae challenged with H305 S. pyogenes (doses as shown) 
(n=25-30). (A). p= 0.0240 (*), p= 0.0028 (**).  All dose titration experiments (9) at 66 hpf 
were combined into one figure, and a linear regression line was drawn (B). 
C,D) In vivo growth of S. pyogenes H305 in zebrafish embryos. The infectious dose was 28 
CFU. At each time point, at least 5 live embryos and all dead ones were collected, 
homogenised, and 10 μL were plated on THY omni trays. Live embryos are marked with 







3.8.1 Choosing the systemic model of infection  
 
The site of infection chosen was into the circulation valley resulting in systemic 
disease. Within the zebrafish embryo, there are several infection sites to select from, 
the circulation valley (systemic), the otic vesicle, somites (tail muscle) and yolk, to 
name a few (Prajsnar et al., 2008, Harvie and Huttenlocher, 2015, Benard et al., 
2012). Apart from asymptotically colonising the nasopharynx, S. pyogenes, can also 
become invasive and cause lethal infection, which leads to its notoriety as an agent 
of necrotising fasciitis and streptococcal toxic shock syndrome (STSS) (Stevens, 
2000). Introducing S. pyogenes into the bloodstream creates a potential interaction 
between the pathogen and the host immune phagocytes. This provides an excellent 
opportunity to examine the role of phagocytes in the control of S. pyogenes disease. 
Furthermore, the model is versatile to allow the potential of the newly described 
phenomenon of pathogenesis augmentation to be examined (Boldock et al., 2018).  
 
3.8.2 2-dpf embryos offer an amenable model to study S. pyogenes 
infection  
 
Previously, 1 dpf embryos have been used to establish models for S. aureus and E. 
faecalis disease (Prajsnar et al., 2008, Prajsnar et al., 2013). For that reason, the 1 




embryos was appropriate for the H293 strain, but not for HSC5, as a dose of 50 CFU 
led to an almost 50% mortality in the first 12 hpi with that increasing up to 94% by 
24 hpi. This was too rapid for amenable experimentation. 
 
Consequently, the 2 dpf model was examined, which resulted in both strains yielding 
a wider range of dose-dependent mortalities, likely as the immune system had more 
time to develop. Giving a long window for infection to progress provides the 
opportunity to observe pathogen dynamics within the context of a host, for which the 
immune system has not been overwhelmed. It is also important to be able to use an 
infectious dose that is high enough to allow reproducible infection but not so large 
that the material infected per se has an undue deleterious effect on the host. For 
these reasons, the 2 dpf model was used henceforth. 
 
3.8.3 H293 S. pyogenes strain allows for examination of the infection 
bottleneck 
 
All three S. pyogenes strains used here, yielded dose-dependent survival, with 
virulence going H305>HSC5>H293. In vivo growth experiments showed that 
virulence was linked to bacterial growth for all strains. For H293, growth was 
restricted between 2-8 hpi. This bottleneck was followed by a bifurcation of zebrafish 
hosts; ones carrying about 106 CFU, and the others 101-103. This bottleneck was 
not found in the other two strains. Instead, S. pyogenes CFU numbers were found 




also observed, with H305 showing it as early as the first couple of time-points. Given 
that HSC5 and H305 produced a much higher fish mortality than H293, their 
bottleneck had likely been resolved by 2 hpi, thus not being detected by the time-
points chosen for the experiment. The resolution of this bottleneck reveals the fate 
of the host; either being overwhelmed or having seemingly cleared the infection. It 







Chapter 4: Investigating host-pathogen interactions in the 




Zebrafish embryos show no markers of adaptive immunity in their first four days, 
after which T and B cells start developing to eventually establish the adaptive 
system. The adaptive immune response, however, is only functional four to six 
weeks later (Sullivan et al., 2017). Conversely, functional macrophages and mature 
neutrophils have been reported to be present within 25 hpf (Herbomel et al., 1999) 
and 48 hpf (Lieschke et al., 2001) respectively. This isolation of the innate immune 
system reactions, allows for studying the innate responses without complications by 
the adaptive response. In order to study host-pathogen interactions during infection, 
specific tools for spatial and temporal imaging in a living fish need to be used. 
Several transgenic fish lines that have fluorescent tags on professional phagocytes 
have been created and used in previous studies (Renshaw et al., 2006, Hall et al., 
2007, Prajsnar et al., 2012). In the same manner, fluorescent labels can be created 
for the bacterial strains in use. Together, visualisation of both leukocytes and 





Another way of interrogating the role of the innate immune system in fighting S. 
pyogenes, is by knocking-down individual elements of the system itself to identify 
their role. One of the knock-down technologies are the antisense, morpholino-
modified oligonucleotides (morpholinos). Morpholinos block specific gene 
expression by targeting mRNA transcripts at translation (Nasevicius and Ekker, 
2000). For instance, a morpholino against pu.1 can be used to block the expression 
of this myeloid cell transcriptional activator in 1-4 cell embryos (Rhodes et al., 2005, 
Prajsnar et al., 2008). This, yields both phagocyte cell types being depleted, with 
macrophages not developing until 48 h, and neutrophils being retarded by 36 h. This 
knock-down effect is only transient, and eventually gene expression resumes. 
Another knock-down technique that will be used in this Chapter, is chemical ablation 
of specific phagocyte types. For example, the injection of liposome-encapsulated 
clodronate in 1 dpf fish, results in the neutralisation of macrophages by 2 dpf (van 
Rooijen and Hendrikx, 2010, Nguyen-Chi et al., 2017). 
 
4.2 Aims of this chapter 
 
1. Visualise spatial and temporal interactions between S. pyogenes and 
professional phagocytes. 
2. Genetically disrupt the myeloid cell lines in order to elucidate the role of 







4.3.1 pHrodo staining of S. pyogenes injected in zebrafish embryos. 
 
In order to investigate host-pathogen interactions, the first question to be addressed 
was whether or not S. pyogenes is phagocytosed. To that end, S. pyogenes H293 
was stained using red pHrodo (ThermoFisher Scientific). pHrodo is a fluorescent 
dye that binds to the cell wall of bacteria. It remains almost non-fluorescent at neutral 
pH, but at a pH below 5, it fluoresces brightly. As a consequence, in the case that 
S. pyogenes is phagocytosed and ends up in a phagolysosome, this event would be 
detected by the microscope as increased fluorescence in that acidified environment 
(Zhu et al., 2015). S. pyogenes H293 was prepared by incubation with pHrodo as 
described in Section 2.19. 
 
A group of larvae was injected with 800 CFU of S. pyogenes H293 stained with 
pHrodo, and after 1-2 hours, three live embryos were chosen to be imaged by 
confocal microscopy. Figure 4.1 is a representative picture from the three embryos, 
and it shows the stained bacteria fluorescing inside what are presumably 
phagocytes, suggesting that S. pyogenes was phagocytosed. These cells were 
situated at the outer surface of the embryo yolk sac, where phagocytes stay attached 
to the plasma membrane of the sac, unlike the evermoving red blood cells (Herbomel 





4.3.2 Creating fluorescently-labelled S. pyogenes  
 
In order to be able to monitor host-pathogen interactions in real-time, a permanent 
label is needed for S. pyogenes. The pHrodo dye only provided a temporary solution, 
as the dye binds to the cell wall and gets subsequently diluted as bacteria grow. For 
this reason, the pMV158-mCherry and pMV158-GFP plasmids were introduced into 














Figure 4.1 pHrodo stained S. pyogenes was internalised by likely embryo phagocytes 
Zebrafish embryos were injected with 800 CFU S. pyogenes stained with pHrodo™, and 
imaged after 1-2 hours using a confocal microscope. Three embryos were picked to be 
imaged, and a representative image was chosen to be presented here. These cells were 
situated in the circulation over the yolk of the fish, and were captured at 60x magnification. 



















Figure 4.2 Transformation confirmation of pMV158-GFP and pMV158m-Cherry in 
H293  
S. pyogenes H293, was transformed with either pMV158-GFP or pMV158-mCherry via 
electroporation. After the recovery step, the resuspended cells were plated on Columbia 
horse Blood Agar (CBA), with no antibiotics. This figure presents four different CBA plates, 
viewed under a stereomicroscope. The strains also grew on THY-tet plates, but with a 





4.3.3 Whole fish microscopy of S. pyogenes during the initial and 
terminal stages of infection 
 
Zebrafish embryos were challenged with 500 CFU of H293 carrying pMV158-GFP. 
Following, 1 hour of incubation at 28°C, three live fish were imaged via confocal 
microscopy (Figure 4.3). At 2x magnification, all three fish had the same two areas 
where bacterial foci were mainly aggregated; the area below the circulation valley, 
and the end of the tail (Figure 4.3A). In order to visualise the host-pathogen 
interactions at the cellular level, the tail region was chosen to be looked at, at 60x 
magnification (Figure 4.3B). It could be observed that most labelled bacteria had 
already been phagocytosed, as most of them could be seen inside cells. S. 
pyogenes was observed to be successfully phagocytosed as early as 0.5 hpi (data 
not shown). Here, colocalization of bacteria with phagocytic cells is considered as 
phagocytosis. These cells could be either macrophages or neutrophils, as both types 







At 20 and 26 hpi, six more larvae were collected in random, three per time-point, 
and imaged (Figure 4.4). Figure 4.4A shows a fish that was collected very shortly 
after its terminal stage, which was determined by loss of heartbeat but no 
decomposition. The bacteria could be seen concentrated mainly around the 
circulation valley and the yolk sac, either above or below. Collectively these areas 
are the upper part of the circulation system of the zebrafish, and bacteria were found 
where blood vessels have been reported to be. No bacteria were seen in the yolk. 
Fish 4.4B, was collected after the terminal stage, as can be seen from its 
decomposing state. Having less of a structure, the bacteria could still be mainly 
found around the yolk. No fluorescent S. pyogenes was detected in fish 4.4C, which 

















Figure 4.3 Imaging of disseminated bacterial foci at 1 hpi after systemically 
challenging embryos with GFP-tagged S. pyogenes 
Zebrafish larvae were inoculated with 800 CFU of S. pyogenes H293 carrying pMV158-
GFP. At 1 hpi, three embryos were chosen to be imaged (A). The red arrows show the two 
major aggregation zones, which were just below the circulation valley, and the tail. The three 
embryos were imaged using a 2x magnification (A), whereas a 60x was used to zoom in on 
the tail of one of the embryos (B). The zoomed in area is indicated by the red box outline. 



















Figure 4.4 Visualisation of S. pyogenes localisation at the terminal stage of infection 
versus a cleared infection 
Embryos were injected with 800 CFU S. pyogenes H293-GFP, and three were picked to be 
imaged after 20 (A) and 26 hpi (B, C). No heartbeat could be seen for fish A and B, whereas 
C had no fluorescent S. pyogenes detected, and had a strong heartbeat. Magnification was 





4.3.4 Elucidating the involvement of macrophages and neutrophils 
during infection 
 
Having mapped the spatial arrangement of S. pyogenes, at the beginning and the 
end of the infection, the next goal of this Chapter was to carry out more detailed 
microscopy, defining the role of specific phagocyte types in S. pyogenes infection. 
Therefore, transgenic zebrafish lines were employed, and used in combination with 
the fluorescently-tagged bacteria. S. pyogenes H293 carrying pMV158-GFP was 
injected intravenously into Tg(mpeg1:mCherry-CAAX)sh378 embryos at a dose of 
1850 CFU (Loynes et al., 2018). This line has mCherry labelled macrophages. At 3 
hpi, five fish were chosen to be fixed and imaged. By this time-point, GFP-labelled 
bacteria had been colocalised with macrophages (Figure 4.5A). The tail region of 
the fish was chosen to be imaged, (red box in Figure 4.5A), due to its flat surface 
which made visualisation more optimal.  
In order to determine the action of neutrophils against S. pyogenes, 
Tg(mpx:GFP)i114 embryos were infected with 1780 CFU H293-mCherry (Boucontet 
et al., 2018). After 3 hours of incubation, five larvae were chosen randomly and fixed 
to be imaged the next day (Figure 4.5 B). Although, most bacteria were found in 
clusters, which suggests phagocytosis, many of those mCherry aggregates were 
found to colocalise with what might be unlabelled phagocytes (indicated by white 
arrows). Regardless, unlike with tagged-macrophages, in the case of these GFP-
neutrophils, bacteria could be seen within distinct phagosomes. 
























Figure 4.5 S. pyogenes colocalised with both embryo macrophages and neutrophils 
Confocal microscopy of individual mCherry-macrophages showing GFP puncta (A), and 
GFP-neutrophils showing mCherry puncta (B). S. pyogenes carrying either pMV158-GFP 
(A) or pMV158-mCherry (B) was injected into Tg(mpeg1:mCherry-CAAX)sh378 fish (A), 
and Tg(mpx:GFP)i114 (B) fish respectively. At 3 hpi, five larvae were fixed, and imaged the 
next day. A representative image from the five larvae was chosen to be shown here. The 
60x (A) and 40x (B) objectives were used from a confocal microscope. Scale bars represent 
9 μm. The red box outline on the top, represents the tail area were the imaging took place. 





There have been many reports suggesting that in the context of liquid environments, 
like the bloodstream in the case of a systemic model, macrophages are very efficient 
at taking up bacteria, whereas neutrophils are not (Le Guyader et al., 2008, Colucci-
Guyon et al., 2011, Prajsnar et al., 2012). Neutrophils have been reported to 
demonstrate a “vacuum cleaner” phagocytic behaviour, making them very effective 
on tissue surfaces instead (Colucci-Guyon et al., 2011). This difference between 
macrophage and neutrophil phagocytosis efficiency was observed when 
Tg(mpeg1:mCherry-CAAX)sh378 (mCherry macrophages), and Tg(mpx:GFP)i114 
(GFP neutrophils) zebrafish embryos were inoculated with their respective 
fluorescently labelled S. pyogenes H293 (Figure 4.6). Most of the mCherry-
macrophages present had phagocytosed at least a few bacteria, whereas most of 
the GFP-neutrophils were empty.  
 
To further explore this difference in colocalisation, a different fluorescent dye was 
used with a third colour in order to be able to detect all S. pyogenes, macrophages, 
and neutrophils separately. To that end, H293 was stained with AlexaFluor647, and 
was used to inoculate Tg(fms:GAL4);Tg(UAS:nfsB.mCherry);Tg(mpx:GFP) 
(mCherry macrophages-GFP neutrophils) fish at a dose of 1240 CFU (Prajsnar et 
al., 2012). At 1 hpi, five fish were chosen for live microscopy (Figure 4.7 A). 
Microscopy data from these fish was used for a quantitative assessment of the 
observations via manual counting of puncta within the labelled phagocytes (Figure 





















Figure 4.6  Phagocytosis of S. pyogenes by macrophages vs neutrophils 
Tg(mpeg1:mCherry-CAAX)sh378 embryos were injected with 1850 CFU H293-GFP (A), 
and Tg(mpx:GFP)i114 embryos were inoculated with 1780 CFU H293-mCherry (B). At 3 
hpi, five fish per group were chemically fixed with 4% PFA in PBS as described in 2.17, and 
imaged the following day. The 10x objective was used. The scale bards represent 35 μm. 
























Figure 4.7 Macrophages are more efficient in phagocytosing S. pyogenes than 
neutrophils in the zebrafish systemic model of infection  
S. pyogenes H293 was stained with Alexa647, and subsequently injected intravenously into 
a dually labelled GFP-neutrophils-mCherry-macrophages zebrafish line, at a dose of 1240 
CFU. At 1 hpi, five embryos were chosen for live imaging (A). A confocal microscope was 
used with a 40x objective. The S. pyogenes colour was set to be represented as white for 
contrast. Scale bars represent 17 μm. Images were manually quantified and the percentage 
of macrophages with puncta present over neutrophils is given (n=4 fish, 3 sections per fish, 





A punctum was defined as a phagocytosis event, regardless of the actual number 
of bacteria inside the phagocyte. About 66% of observed macrophages were found 
to have phagocytosed bacteria (puncta), whereas only about 16% of observed 
neutrophils had phagocytosed S. pyogenes. 
 
4.3.5 Imaging the infection progression over the first 8 hpi 
 
It was established in Chapter 3 section 3.3.2., that by 8 hpi, the fate of the embryos 
had been determined with bacterial concentrations being either over 104 and on their 
way to overwhelm the host, or below 102, and the host was clearing the infection. 
Since, the data above suggested that macrophages play a bigger role in 
phagocytosing S. pyogenes, than neutrophils do, visualisation of phagocytosis 
progression was chosen to be assessed by tracking macrophages. Hence, 
microscopy data from the previous experiment using the Tg(mpeg1:mCherry-
CAAX)sh378 line was used.  
 
At three separate time-points, 2, 6, and 8 hpi, five fish were chosen, per time-point, 
and fixed to be imaged the following day (Figure 4.8). At 2 hpi, most of the GFP 
bacteria were found colocalised with macrophages, with a few clusters inside non-
tagged phagocytes, as well as a very small number of bacteria being found outside 





















Figure 4.8  Visualising S. pyogenes progression of infection via macrophage 
phagocytosis over 8 hours 
Tg(mpeg1:mCherry-CAAX)sh378 larvae were challenged systemically with 1850 CFU S. 
pyogenes H293 carrying pMV158-GFP, and imaged after 2, 4, and 6 hpi. The 10x objective 
was used. The scale bars represent 35 μm. The red box outline on the top, represents the 
tail area were the imaging took place. At both 6 and 8 hpi the embryo heartbeat was very 





0.5 hpi (data not shown). At 6 hpi, S. pyogenes had started growing out of control, 
with a significant number of extracellular bacteria being observed as well as a few 
completely saturated macrophages (Figure 4.8 B). By 8 hpi, there were barely any 
macrophages still containing bacteria, and most of the bacteria were extracellular 
(Figure 4.8 C). The fish shown in Figure 4.8, represent hosts that had sufficient 
bacteria to allow for visualisation. No direct link could be drawn between the state of 
the host at the time-point, and its eventual fate. Five hosts were also imaged at 12 
hpi, however the results were that the fish was either too damaged from infection or 
had no detectable bacteria. 
 
4.3.6 Myeloid depletion in zebrafish embryos via a pu.1 morpholino 
 
The microscopy data thus far suggested that both phagocytes were able to take up 
S. pyogenes, with neutrophils being less effective. Since, zebrafish embryos 
younger than 4 weeks only have the innate immune system for protection, the 
hypothesis is that the action of macrophages and neutrophils is the major limiting 
factor that prevents S. pyogenes from uncontrolled proliferation. In order to take a 
more quantitative approach after microscopy, and test this hypothesis, macrophages 
and neutrophils were knocked-down via different techniques, and embryo survival 





An antisense morpholino oligonucleotide (morpholino), against the PU.1 
transcription factor, was used to knock-down myeloid cell development in LWT fish 
(Nasevicius and Ekker, 2000, Rhodes et al., 2005, Prajsnar et al., 2008). These 
knock-down embryos were then challenged at 2dpf, with 100 CFU of S. pyogenes 
H293, and a 100% mortality was seen at 24 hpi, compared to the 40% of WT 
embryos (Figure 4.9 A). The same striking drop in survival was observed with 
smaller inocula as small as 23 CFU (Figure 4.9 B).  
 
An additional experiment was undertaken to illustrate the effect of the absence of 
the phagocytes on S. pyogenes localisation. A group of LWT embryos, and a group 
of pu.1 knock-down larvae were injected with 1500 and 50 CFU, respectively, of 
H293-GFP (Figure 4.9 C, D).  In LWT fish, at 19 hpi, the bacteria were restricted, in 
a very defined way, within the main vessels of the embryo vasculature that spans 
from the heart to the tail, with the biggest and most concentrated focus being the 
heart (Figure 4.9 C). In the morphants on the other hand, the bacteria had almost 
homogeneously dispersed across the entire fish, implying uncontrolled bacterial 



























Figure 4.9  pu.1 knock-down zebrafish larvae are significantly more susceptible to S. 
pyogenes  
A,B) Survival rate curves of myeloid-depleted zebrafish larvae after injecting with S. 
pyogenes H293 intravenously at 100 (A) and 23 CFU (B). p<0.0001 (****) for pu.1 
knockdown compared to WT embryos. PBS was injected for the non-infected controls, and 
the standard morpholino (std mo) was used to control for the morpholino. n=26-30.  
C,D) LWT larvae were injected with 1500 (C) and 50 CFU (D) S. pyogenes H293 carrying 
pMV158-GFP, and imaged after 19 hpi. Both embryos had no heartbeat. The 4x objective 





4.3.7 irf8 knock-down in zebrafish larvae 
 
Interferon regulatory factor-8 (irf8) or interferon consensus sequence-binding 
protein, is mainly expressed in macrophages, lymphocytes, and dendritic cells (Li et 
al., 2011). It is required for myeloid cell progenitors to differentiate to macrophages 
however, it is not needed for differentiation into neutrophils. As a result, a knock-
down of irf8 replaces all host macrophages with neutrophils as the progenitors are 
pushed towards developing almost solely into neutrophils (Li et al., 2011, Nguyen-
Chi et al., 2017). Despite the fact that macrophages are depleted, the total number 
of phagocyte population remains the same.  
 
The irf8 MOatg morpholino was used in order to remove macrophages from 
Tg(mpx:GFP)i114 larvae. At 2 dpf, the embryos were then inoculated with 104 CFU 
S. pyogenes H293. At 18 hpi, 96% mortality was observed in macrophage depleted 
hosts, as opposed to 20% mortality in WT embryos (Figure 4.10 A). A subsequent 
experiment used a 18 CFU dose, which yielded 25% mortality at 18 hpi, but a 96% 
mortality by 48 hpi (Figure 4.10 B). irf8 knock-down and control LWT fish were 
injected with S. pyogenes carrying pMV158-GFP, to examine the effect of 


























Figure 4.10  irf8 knock-down zebrafish larvae are more susceptible to S. pyogenes  
A,B) Survival rate curves of irf8-depleted Tg(mpx:GFP)i114 larvae after injecting with S. 
pyogenes H293 intravenously at 104 (A) and 18 CFU (B). PBS was injected for the non-
infected controls. p<0.0001 (****). 
C,D) LWT larvae were injected with 1500 (C) and 50 CFU (D) S. pyogenes H293 carrying 
pMV158-GFP, and imaged after 19 hpi. The 4x objective was used. The scale bars 





4.3.8 Use of clodronate liposomes for macrophage ablation 
 
After having depleted the hosts of both phagocytes and seeing such a striking 
phenotype (Figure 4.9), the next step was to interrogate the role of macrophages 
specifically, by using liposome-encapsulated clodronate to neutralise them. This 
chemical approach comprises of injecting liposomes filled with clodronate (L-
clodronate) intravenously into 1 dpf embryos, which reduces the number of 
macrophages efficiently after 24 h (van Rooijen and Hendrikx, 2010, Nguyen-Chi et 
al., 2017).  
 
Biphosphonate dichloromethylene-biphosphonate (clodronate) is a small strongly 
hydrophilic molecule, that can be encapsulated within liposomes. Due to its 
hydrophilic properties, the leakage from liposomes is very low, as it cannot easily 
cross any phospholipid bilayers. This also means, that it cannot escape from the 
cytoplasm of any cell it is in. Once L-clodronate is administered to the fish via 
intravenous injections, it naturally ends up being phagocytosed mainly by 
macrophages. Within the macrophages, the phospholipid bilayer of L-clodronate 
gets lysed, releasing clodronate within the cell. As they cannot escape the 
cytoplasm, clodronate concentration will increase to a level that will eventually 
induce apoptosis (van Rooijen et al., 1996). Any free clodronate released following 
macrophage apoptosis, will be removed from the bloodstream since their circulation 





A group of LWT embryos was injected at 1 dpf with L-clodronate to substantially 
reduce the number of macrophages. The fish were then injected with 128 CFU of S. 
pyogenes H293 at 2 dpf (Figure 4.11). At 24 hpi, there was a dramatic 100% 
mortality of macrophage depleted hosts, compared to 23% of immunocompetent 
hosts injected. Injection of L-PBS resulted in 14% mortality, however, the difference 
between L-clodronate injected and either L-PBS injected or just S. pyogenes was 
statistically significant with p<0.0001 (Figure 4.11 A). A small group of 
Tg(fms:GAL4);Tg(UAS:nfsB.mCherry);Tg(mpx:GFP) (mCherry macrophages-GFP 
neutrophils) larvae were injected with either L-PBS or L-clodronate. At less than 1 
hpi, 3 fish were chosen from each group, fixed, and imaged, to assess macrophage 
ablation (Figure 4.11 B). The number of mCherry-labelled macrophages was lower 
in L-clodronate injected fish (Figure 4.11 C) compared to L-PBS injected ones 
(Figure 4.11 B), being consistent with the survival curves (Figure 4.11 A). This was 
quantified manually, with the L-PBS image having 28 macrophages compared to the 
























Figure 4.11  Macrophages are required for a successful defence against S. pyogenes   
A) Survival of macrophage-ablated larvae after injecting with S. pyogenes H293 
intravenously at 128 CFU. Macrophages of larvae were ablated using L-clodronate 
injections at 1 dpf. L-PBS and L-clodronate were used for negative controls. The two control 
lines overlap, showing 100% survival. This graph represents three repeats. n=26-30. 
p<0.0001 (****). 
B,C) Tg(fms:GAL4);Tg(UAS:nfsB.mCherry);Tg(mpx:GFP) embryos were injected with L-
PBS (B) and L-clodronate (C). Embryos were then fixed and their lower tail section was 
imaged at 28 h post injection via confocal microscopy. This line carries mCherry-






4.3.9 Metronidazole treatment for effective ablation of neutrophils 
 
After having used macrophage ablation techniques, a different transgenic approach 
was employed to test for the effect of the absence of zebrafish neutrophils on S. 
pyogenes infection. There are zebrafish lines that express the nitroreductase (NTR) 
enzyme from Escherichia coli, that can be placed under the control of either 
neutrophil- or macrophage-specific promoters. NTR can reduce the non-toxic drug 
metronidazole (Mtz) into a cytotoxic DNA cross‐linking agent inside the cells that 
express it, triggering cell death (Curado et al., 2007, Hall et al., 2009). This technique 
allows for a specific and inducible way to ablate either neutrophils or macrophages, 
and it was reported to have no effect on non-genetically labelled cell populations 
(Prajsnar et al., 2012).  
 
At 34 hpf, Tg(lyz:nfsB-mCherry)sh260 (NTR, mCherry neutrophils) embryos were 
treated with 10 mM Mtz overnight (Buchan et al., 2018). At 54 hpf, the neutrophil-
depleted larvae were injected with 468 CFU of GFP-labelled S. pyogenes. A few fish 
were also fixed and imaged to assess ablation efficacy (Figure 4.12 C,D). There was 
a significant drop in survival for hosts that were treated with Mtz compared to the 
untreated group (Figure 4.12 A). The survival value for the untreated group was also 
relatively lower compared to when injecting LWT fish. In order to examine whether 
this change in mortality was due to the fish line, Tg(lyz:nfsB-mCherry)sh260 fish 
were injected along with LWT fish (Figure 4.12 B). The observed mortality of 256 




had a much lower survival, suggesting that the line was generally more susceptible 
to infection. Figure 4.12 B, also demonstrated that Mtz treatment can weaken the 
host regardless of NTR expression. For that reason, subsequent experiments 
sought to interrogate the effect of Mtz concentration to larvae susceptibility (Figure 
4.13). It was shown that 157 CFU of S. pyogenes yield 23% mortality in untreated 
LWT fish, but as high as 49% mortality in 10 mM Mtz treated LWT fish. A worse 
effect was observed at 6.5 mM Mtz. This data implies that Mtz is harmful to the host, 




























Figure 4.12  Metronidazole treatment effectively ablates neutrophils  
A,B)Survival of Mtz-treated Tg(lyz:nfsB-mCherry)sh260(A) and LWT and Nacre 
zebrafish(B) after being challenged with 468 CFU(A) and 256 CFU(B) S. pyogenes H293. 
(A)p<0.0001 (****), (B)p=0.0029 (**) (LWT) and p=0.0318 (*) (lyz:nfsb). Larvae were 
bathed in Mtz without the presence of bacteria for the negative control.  
C,D)Tg(lyz:nfsB-mCherry)sh260 larvae were injected with 468 CFU S. pyogenes H293 
carrying pMV158-GFP. Hosts were imaged at 19 hpi with the 4x objective. The scale bars 





















Figure 4.13  Metronidazole renders zebrafish embryos more susceptible to infection 
regardless of NTR expression 
Survival rate curves of LWT larvae using various concentrations of Mtz, and injecting with 
157 CFU of S. pyogenes H293. p=0.0157 (*) and p<0.0001 (***). The 0 and 10 mM control 







Zebrafish up to 5 dpf, only have a functional innate immune response, and this 
isolation allows for an interrogation of the innate immune system without any 
adaptive response. A number of reports have suggested that the action of the innate 
immune system is more important than that of the adaptive for S. pyogenes infection. 
Macrophage ablation results in a significantly higher mortality as well as bacterial 
dissemination in hosts (Goldmann et al., 2004, Mishalian et al., 2011). On the other 
hand, S. pyogenes showed a similar mortality in mice with depleted B cells and T 
cells, when compared to their respective immunocompetent control (Medina et al., 
2001). In order to examine if the same response occurs in the zebrafish embryos 
too, as well as to elucidate the role of specific phagocyte types during infection, 
microscopy and several knock-down techniques were employed in this chapter.  
 
To begin with, the use of transgenic zebrafish lines, with fluorescently labelled 
macrophages or neutrophils, demonstrated that both macrophages and neutrophils 
are able to phagocytose S. pyogenes during infection. Fish injected with labelled 
bacteria and imaged at different time-points showed that as early as 0.5 hpi, most 
of the bacteria had been phagocytosed, but by 6-8 hpi, phagocytes had been 
saturated with bacteria, and there was a significant increase in extracellular S. 
pyogenes. By 12 hpi, the fish that would be overwhelmed, were already at a terminal 
stage. This data implies S. pyogenes intracellular growth or at least survival within 




S. pyogenes has been shown to survive in human macrophages (Thulin et al., 2006, 
O’Neil et al., 2016), epithelial cells (Marouni and Sela, 2004), and endothelial cells 
(Amelung et al., 2011). However, the majority of these studies were carried out using 
emm1 strains. Specifically, O’Neil et al demonstrated intracellular replication of S. 
pyogenes emm1 strains within macrophages (O’Neil et al., 2016). S. pyogenes has 
also been shown to persist in mouse neutrophils (Medina et al., 2003), and within 
epithelial cells for days (Kaplan et al., 2006). Regardless, many strains are unable 
to grow intracellularly, and it has been suggested that antibacterial autophagy could 
be a means to eradicate S. pyogenes from the host (Kaur et al., 2010; Sakurai et 
al., 2010; Amelung et al., 2011). Macrophages were additionally indicated as the 
primary reservoir of viable S. pyogenes, as a study found high bacterial numbers in 
spite of antibiotic treatment intravenously (Thulin et al., 2006). Further evidence 
implicated the S. pyogenes M1 surface protein in making S. pyogenes resistant 
against fusion with macrophage enzymolytic vesicles (Staali et al., 2006; Hertzén et 
al., 2010). The role of macrophages, potentially serving as a reservoir in S. pyogenes 
infection, is explored in the next Chapter.  
 
In order to further analyse the role of specific phagocyte cell types, knock-down 
techniques have been employed in infection models, to look at the effect of 
phagocytes on host survival. In S. aureus, use of pu.1 and irf8 morpholinos, showed 
that phagocytes, and specifically macrophages (for irf8), are very important against 
the infection (Prajsnar et al., 2008, 2012). In this study, this was also observed. A 




(macrophages and neutrophils) (Nasevicius and Ekker, 2000, Rhodes et al., 2005). 
This yielded a rapid death of hosts, and at a significantly lower dose, when compared 
to immunocompetent embryos. Microscopy data also demonstrated that the bacteria 
had spread and grown at a much larger scale, than in the WT fish, at the same time-
point. This data suggests that phagocytes are paramount in controlling invading 
pathogens in the bloodstream. However, this technique did not address whether or 
not a specific phagocyte type is more important in conferring a higher resistance 
against S. pyogenes. Using a dually-labelled mCherry-macrophage/GFP-
neutrophils line, it was observed that, albeit both phagocytes being able to 
phagocytose bacteria, macrophages were more efficient at it, when examining the 
bloodstream.  
 
irf8 knock-down fish, develop all of their potential macrophages into neutrophils, 
effectively depleting the host of any macrophages (Li et al., 2011, Nguyen-Chi et al., 
2017). This resulted in a reduction in survival compared to WT hosts, but not as 
dramatic as the removal of pu.1. This suggested that the presence of macrophages 
is a major defence factor during infection. Additionally, it showed that neutrophils by 
themselves, are not able to mount an effective response, even when they are 
present in higher numbers than those in WT fish.  
 
L-clodronate injections were used to achieve macrophage-specific ablation in 




liposomes were naturally phagocytosed by macrophages, broken down, and the 
clodronate initiates apoptosis. Microscopy data showed that ablation was effective. 
Macrophage-depleted embryos were hypersusceptible to S. pyogenes. This 
confirmed that macrophage action is very important during infection. 
 
Using the prodrug metronidazole (Mtz) to treat neutrophil NTR-expressing zebrafish, 
produces a neutrophil depleted line (Curado et al., 2007, Hall et al., 2009). This 
experiment tested the importance of neutrophils. The results showed that despite 
the absence of neutrophils resulting in a significantly lower survival of hosts, it did 
not produce the observed 0% survival that PU.1 ablation yielded.  
 
There are many studies that support this finding, suggesting that macrophages can 
engulf bacteria with significantly greater efficacy in fluid-filled environments, ie. the 
bloodstream, than neutrophils that barely do so (Le Guyader et al., 2008, Colucci-
Guyon et al., 2011, Prajsnar et al., 2012). To take it a step further, Colucci-Guyon 
and colleagues, suggested that macrophages are very efficient phagocytes 
regardless of how the microbes are being presented, unlike neutrophils that are 





Chapter 5: Elucidation of population dynamics during S. 




The work presented in this Chapter sought to interrogate the bottleneck 
phenomenon exerted by the zebrafish immune system in response to S. pyogenes, 
as well as investigate the potential effect commensals might have on infection. To 
that end, a co-infection of differently fluorescently tagged, but otherwise isogenic, 
emm89 strains was carried out, monitored and documented. Different ratios of 
pathogenic and non-pathogenic bacteria or their cell wall components, were also 
injected in embryos in order to determine the impact of commensals on S. pyogenes 
infection. More specifically, M. luteus, and M. luteus and S. aureus peptidoglycan 
were examined. 
 
5.2 Aims of this chapter 
 
1. Assess the bottleneck effect on S. pyogenes infection. 








5.3.1 Population dynamics during the S. pyogenes infection  
 
The same two H293 strains, containing pMV158-GFP and pMV158-mCherry, used 
for microscopy in Chapter 4 were also used here. This ensured that genetic 
background would not be one of the contributing factors during the bottleneck. LWT 
zebrafish embryos were injected with an initially designed 1:1 ratio of each of the 
two isogenic emm89 strains (pMV158-GFP, pMV158-mCherry) in the circulation 
valley at a dose of 2717 CFU resulting in a 31% survival (Figure 5.1A). At 20 hpi, 9 
fish were chosen, homogenised, and plated on THY plates. CFU counts permitted 
the quantification of the distribution of GFP and mCherry strains that comprised the 
final S. pyogenes population that overwhelmed the fish (Figure 5.1C). However, it 
was observed that a number of bacteria had lost their fluorescence in both the doses 
check stage and when plating the homogenised embryos.  
 
As can be seen in Figure 5.1B, despite the fact that the GFP and mCherry emm89 
cultures were prepared to have a very similar OD600, mCherry bacteria (1394 CFU) 
were almost three times the amount of GFP (516 CFU). Moreover, there were 
bacteria with no fluorescence (808 CFU), at a number 1.5 times greater than that of 
the GFP colonies. Both the original doses and the homogenised larvae were plated 
on THY media. The bacteria were distinguished from one another by checking for 




were picked, and their bacterial load and population ratios were analysed. In fish 1 
to 3, no bacteria could be seen at 4x under the microscope, and the fish had a strong 
heartbeat as well as no signs of any lesions. These three fish had small bacterial 
loads: 160, 1600, 4200 CFU respectively. Fish 5 to 9 had no heartbeat, and clearly 
formed lesions, implying their terminal stage of infection. Fish 4 had CFU almost as 
high as fish 5 to 9, but instead had a strong heartbeat, and no lesions were visible 
(3x104 CFU). 
 
Despite the mCherry:GFP ratio being almost 3:1 in the co-inoculum, in the four live 
fish (fish 1-4), the output population of S. pyogenes was not always symmetrically 
distributed (Figure 5.1C). Fish 1 had no unmarked colonies and the mCherry were 
almost twice the number of GFP colonies. On the contrary, fish 2, had no mCherry 
colonies, but instead was dominated by GFP bacteria. Fish 4 had no GFP colonies, 
and a close to 2:1 ratio of mCherry to unmarked colonies. For the hosts that had 
succumbed (fish 5-9), the three populations were evenly spread, with bacterial 
numbers being between 8.8x104 and 1.66x105 CFU. 
 
Unfortunately, fish1-4 had too low of a bacterial load to allow for direct observation 
in vivo via fluorescence. Fish 5-9 were imaged just before being homogenised 
(Figure 5.2). There were many lesions throughout the larvae indicating the late 
progression of the infection. In a few cases, there were lesions that were formed by 















      
 
 
Figure 5.1 S. pyogenes population dynamics reveal polyclonality 
A,B)Survival of LWT zebrafish upon infection with 2717 CFU of a mixture of pMV158-GFP 
and pMV158-mCherry S. pyogenes emm89 (n=58) (A), and their CFU dose ratios (B).  
C)Distribution of GFP, mCherry, and non-fluorescent bacteria counted after homogenising 
9 collected embryos. The bacteria were plated on THY media and counted under a 












































Figure 5.2 Visualisation of S. pyogenes population dynamics 
A-E)In vivo images of fish 5-9 from Figure 5.1C that succumbed to infection (20 hpi), after 
being inoculated with 2717 CFU of a 3:1 mixture of mCherry- to GFP-labelled S. pyogenes 
emm89. Images were captured using a Nikon custom widefield microscope at 4x, with 
brightfield, mCherry, GFP, and merged views shown. Scale bars represent 500μm.  






were created by two strains that were colocalised (Figure 5.2A’), or a combination 
of the two within an individual host (Figure 5.2D’).  
 
5.3.2 Does the augmentation phenomenon occur during S. pyogenes 
infection?  
 
5.3.2.1 The effect of the skin commensal M. luteus on S. 
pyogenes infection 
 
As mentioned in the Chapter 1, previous work by Boldock and colleagues, 
established a phenomenon called augmentation in which the presence of a avirulent 
bacterium can enhance the virulence of a pathogen (Boldock et al., 2018). This 
presented an opportunity to explore the breadth of this phenomenon to other 
pathogens. One of the initial hypotheses of this observed enhanced virulence, was 
that by adding a second organism, the phagocytes would be pushed to their limit 
and be overwhelmed. This would exert less pressure on the pathogen, being at 
numbers smaller than the commensal, which would be free to colonise, grow and 
employ its virulence factors. This hypothesis was disproved by showing that the 
presence of latex beads, although being successfully phagocytosed, did not 
augment S. aureus pathogenesis, even with a dose as high as 9000 beads (Boldock 















Figure 5.3 Skin commensal M. luteus has no effect on S. pyogenes infection. 
Survival of LWT zebrafish larvae injected with M. luteus (2075 CFU), a low dose of S. 
pyogenes H293 (151 CFU) or a combination (2833 and 390 CFU respectively) (n=25-30). 






In order to assess whether this augmentation phenomenon can occur during an S. 
pyogenes infection, LWT zebrafish embryos were challenged with a combination of 
a low dose of S. pyogenes H293 and M. luteus. Given the fact that S. pyogenes can 
gain entry from skin breakage, M. luteus was used as it is a commensal that is part 
of the skin milieu (Davis C.P., 1996). M. luteus injected at 2075 CFU in zebrafish 
embryos yielded 100% survival (Figure 5.3). The low dose of S. pyogenes H293 at 
151 CFU yielded 69% survival, whereas the co-inoculum of 390 CFU of H293 and 
2833 CFU M. luteus resulted in 71% survival. There was no statistical significance 
between the two latter groups.  
 
5.3.2.3 Elucidation of the role of cell wall peptidoglycan in 
augmentation of S. pyogenes infection  
 
   5.3.2.3.1 Effect of M. luteus peptidoglycan on S. pyogenes 
infection 
 
Although, live M. luteus was unable to elicit the augmentation effect when co-
injected with S. pyogenes, in order to further examine the potential for augmentation 
another approach was taken. Boldock et al (2018) showed that isolated cell wall 
peptidoglycan from a number of Gram-positive bacteria, including M. luteus, was 





Peptidoglycan (PG) is the major component of the cell wall of Gram-positive 
bacteria. PG has been shown to provide a stimulus for the host immune system and 
is involved in S. aureus pathogenesis (McDonald et al., 2005). In order to explore 
the potential effect of PG on S. pyogenes infection, preparations of purified M. luteus 
and S. aureus cell wall peptidoglycan were individually co-inoculated with a number 
of doses of S. pyogenes H293. PG was first stripped of additional components that 
could also modulate a response of the host, and materials used in this study were 
provided by Dr Josie Gibson and Mr Josh Sutton. Amounts of PG injected were used 
as per Boldock et al (2018).  
 
Injecting 25-30 individual zebrafish per group, 5 ng of M. luteus peptidoglycan alone, 
was found to cause no host mortality (Figure 5.4 A). In combination with a low dose 
of 34 CFU of S. pyogenes, it did not trigger a significant decrease in host survival. 
The same was observed when increasing the pathogen dose to 500 CFU (Figure 
5.4 B). At 1200 CFU of S. pyogenes mixed with 5 ng M. luteus PG, a dramatic 
increase in host mortality was noted compared to 1200 CFU of the pathogen alone 
(Figure 5.4 C). Doubling the M. luteus PG concentration to 10 ng, was not toxic to 
the host. When co-injecting 10 ng of M. luteus PG with 363 CFU of S. pyogenes 
H293 systemically, a statistically significant drop in survival was seen (Figure 5.4 D). 
Challenging the hosts with 1260 CFU of S. pyogenes and 10 ng M. luteus PG, gave 
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Figure 5.4 Examining the effect of M. luteus cell wall peptidoglycan on S. pyogenes 
pathogenesis 
M. luteus purified peptidoglycan 5 ng (A, B, C) and 10 ng (D, E) was co-injected with different 
doses of S. pyogenes H293 as shown, into the zebrafish circulation valley to test for the 






5.3.2.3.2 Effect of S. aureus peptidoglycan on S. pyogenes 
infection 
 
Various doses of S. pyogenes H293 and S. aureus SH1000 PG were injected into 
the zebrafish circulation valley to test for the effect of S. aureus cell wall 
peptidoglycan on S. pyogenes infection (Figure 5.5). Neither 8 ng nor 16 ng of 
SH1000 PG injected to the fish yielded any host mortality. Mixed inoculum assays 
of 8 ng of PG and either 75 or 740 CFU of S. pyogenes did not produce any 
significant differences from infecting the hosts with the pathogen alone (Figure 5.5 
A, B). Although there was an increase in mortality with the addition of 16 ng PG into 
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Figure 5.5 S. aureus peptidoglycan has no effect on S. pyogenes virulence 
Testing for the augmentation effect by injecting systemically S. aureus SH1000 purified 
peptidoglycan, 8 ng (A, B) and 16 ng (C), with S. pyogenes H293 (numbers as shown) into 





5.3.2.5 In vivo zebrafish imaging of S. pyogenes co-inoculated 
with M. luteus peptidoglycan 
 
To further investigate any potential immuno-stimulatory role of peptidoglycan, in vivo 
imaging using labelled host macrophages, S. pyogenes H293, and M. luteus 
peptidoglycan, was conducted. In order for this experiment to be carried out, the 
Tg(mpeg1: mCherryCAAX) zebrafish line, with mCherry-labelled macrophages, was 
used. Three groups of larvae from this line, were injected systemically with 5 ng of 
M. luteus peptidoglycan dyed with AlexaFluor 405 alone, 583 CFU S. pyogenes 
H293 carrying pMV158-GFP alone, and then a mixed inoculum of both 408 CFU of 
the pathogen and 5 ng of PG. At 0.5, 5.5 and 18.5 hours post bacterial challenge, 5 
individual hosts were removed and fixed for imaging. All images were acquired via 
confocal microscopy.  
 
At 0.5 hpi, albeit, some of the M. luteus peptidoglycan could be seen colocalised 
within macrophages, most of it was not (Figure 5.6). What was observed can be 
almost described as “a sea” of peptidoglycan. In spite of this experiment being 
unable to confirm phagocytosis, the shape of PG aggregates that fit the shape of the 
colocalising macrophage, served as an indirect confirmation. As the fish were fixed, 
and this was not live imaging, it was not possible to infer if the PG particles were 
moving or were stuck on surfaces. This excess of peptidoglycan pattern remained 
throughout all three time-points, including fish that had successfully cleared the 

















Figure 5.6 Confocal microscopy of labelled M. luteus cell wall peptidoglycan in fixed 
zebrafish embryos 
Zebrafish embryos were systemically infected with AlexaFluor 405-labelled M. luteus 
peptidoglycan (5 ng). At 0.5 hpi, five individual hosts were removed and fixed. The image 
shown here is representative of the five individual hosts. The images were acquired at 40x. 
The scale bars represent 17 μm. The red box outline on the top, represents the tail area 
were the imaging took place. (A’)Blow up of Merged image showing colocalization of 
macrophages and PG. 
  






(data not shown). In the zebrafish embryos that were co-injected with S. pyogenes-
GFP and PG, the pattern of excess PG was still observed at 0.5 hpi. M. luteus PG, 
however was found to colocalise with S. pyogenes within macrophages, while most 
of the pathogen was found within the phagocytes (Figure 5.7). At 5.5 hours after 
challenge, the larvae removed from the ones injected with the mixed inoculum of S. 
pyogenes and PG, had either cleared the infection and barely any bacteria could be 
seen (Figure 5.8 A) or the bacteria had overcome the host system and had replicated 
out of control (Figure 5.8 B). The aim of these experiments was to discover whether 
or not PG colocalised with S. pyogenes and macrophages as reported by Boldock 
et al. 
 
Images from all three groups of embryos at different time-points, were all pooled 
together into one figure to produce a holistic view of the progression of the infection, 
taking all the variables into consideration. As shown in Figure 5.9, the distribution 
and dispersion patterns of PG remain the same regardless of the time-point or the 
presence of S. pyogenes, even at 66 hpi. Most of S. pyogenes was phagocytosed 
by 0.5 hpi, something previously reported in Chapter 4. By 5.5 hours past challenge, 
the pathogen had either been removed or was on its way to overwhelming the fish 
while macrophages were still detectable. At 18.5 hpi, the same dichotomy was 





















Figure 5.7 In vivo microscopy of labelled M. luteus peptidoglycan and S. pyogenes 
H293 co-injected in zebrafish larvae 
Larvae were challenged with a mixed inoculum of 408 CFU GFP-labelled S. pyogenes H293 
and AlexaFluor 405(blue)-labelled M. luteus purified peptidoglycan (5 ng). At 0.5 hpi, five 
individual hosts were removed and fixed. Here, one of five fish is shown. The images were 
acquired at 40x. The scale bars represent 17 μm. The red box outline on the top, represents 
the tail area were the imaging took place. (A’) Enlarged of merged image showing 
colocalization of macrophages, S. pyogenes, and PG. 
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Figure 5.8 Comparative microscopy of overwhelmed and healthy zebrafish embryos 
























































Figure 5.9 Comparative microscopy of zebrafish embryos challenged with a mixed 
inoculum of S. pyogenes-GPF and M. luteus peptidoglycan over 0.5, 5.5 and 18.5 hpi  
Three groups of embryos were injected systemically at 56 dpf. One group was infected with 
M. luteus cell wall peptidoglycan (5 ng) alone (A). The second group was injected with a low 
dose of GFP-marked S. pyogenes H293 (583 CFU) (B). The third group was co-injected 
with both S. pyogenes (408 CFU) and 5 ng M. luteus peptidoglycan (C). At 0.5, 5.5 and 18.5 
hpi, five fish were removed, fixed, and subsequently imaged with a spinning disc confocal 
microscope. Each panel is a different host. The images were acquired at 40x. The scale 
bars represent 17 μm. The red box outline on the top, represents the tail area were the 
imaging took place. 
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In the S. aureus model, in both zebrafish embryos and mice, the infection is 
monoclonal as individual clones were demonstrated to have formed the abscesses 
that led to the host being overwhelmed (Prajsnar et al., 2008, McVicker et al., 2014). 
It was on this premise that this Chapter sought to investigate the clonality of S. 
pyogenes infection. With a 3:1 mCherry:GFP initial dose, the resulting lesions in the 
fish, showed mixed population ratios at the host terminal stage. A combination of 
single colour and mixed colour lesions was observed within the same fish, with CFU 
numbers of the two fluorescent labels being evenly spread in the fish that had 
succumbed. From the four live fish collected, one of the two labelled strains, was 
found to be absent from a few fish. This was determined via homogenising and 
observing CFU numbers under a fluorescent microscope. Taken together, this data 
suggests that many S. pyogenes cells are able to exit the phagocytes, and form 
lesions, revealing polyclonality. Despite a number of S. pyogenes cells losing their 
plasmid, the question this set of experiments attempted to answer was whether the 
lesions were founded by one colour or both. As this question was answered 
regardless of the loss of plasmid, this data constitutes sufficient evidence as a pilot 





Live M. luteus, M. luteus and S. aureus PG do not augment S. pyogenes infection 
The second goal of my study was to use M. luteus and its purified peptidoglycan, 
along with S. aureus peptidoglycan, to test for the augmentation effect during S. 
pyogenes infection. As previously reported, this effect allows for infectious dose to 
drop dramatically for S. aureus. To that end, low doses of S. pyogenes (50 or 500 
CFU) were used in combination with live M. luteus, M. luteus peptidoglycan, or S. 
aureus peptidoglycan. These mixed inocula used low doses of S. pyogenes, and 5 
ng of M. luteus PG as previously described (Boldock et al., 2018). At these doses, 
no statistically significant increase in mortality was noted. Instead, at the highest S. 
pyogenes dose (1200 CFU), mixed with M. luteus PG, a significant decrease in host 
survival was recorded. Furthermore, the same significant decrease in survival was 
seen when using twice the PG concentration. This result, as it only occurs at high 
doses of S. pyogenes and other material, is probably due to overwhelming of the 
phagocytes. In support of a simpler swamping of the phagocyting capacity of the 
immune system, it was observed that although PG could be successfully taken up 
by macrophages at large doses, PG could be seen both inside and outside the cells. 
Despite a number of S. pyogenes bacteria losing their fluorescent label, these 
experiments still allowed for the visualisation of any potential interactions between 











S. pyogenes manifests primarily as minor infections, either associated with the throat 
or the skin (Carapetis et al., 2005). In the less frequent cases when it develops into 
a severe invasive infection, treating it is complicated, and the infection often proves 
fatal. Currently, there is no vaccine available. Although, numerous studies have 
begun to break down and characterise S. pyogenes infections, much is still 
unknown. For that reason, the development of additional infection models, would 
likely help further our understanding of S. pyogenes infection. 
 
My project has established the zebrafish embryo model as a relatively high-
throughput and rapid method of investigating S. pyogenes infection. The three S. 
pyogenes strains H293 (emm89), H305 (emm1), and HSC5 (emm14) were initially 
explored, with the first being chosen due to its amenability to study. Monitoring the 
H293 bacterial burden in vivo over time, revealed the presence of a bottleneck until 
8 hpi, after which there was a bifurcation of zebrafish hosts; one group that 
demonstrated rapid bacterial proliferation and host mortality and one in which a 
decline in bacterial load was seen. Macrophage depletion showed that this 8-hour 
bottleneck, was immunological as also seen in the S. aureus model (Prajsnar et al., 
2012). Real-time visualisation via microscopy of host-pathogen interactions 
revealed bacterial uptake early on, in potentially greater number by macrophages 




bacteria. Population dynamics analysis showed that S. pyogenes infection is 
polyclonal as lesions were founded by many different bacterial cells. Moreover, live 
commensals, or their cell wall peptidoglycan, were co-injected with S. pyogenes in 
order to investigate the presence of the augmentation effect. This effect was not 
observed. All in all, this now established model can add to existing animal models, 
on the way to understanding S. pyogenes infection. It can act as a platform to test 
and refine hypotheses before moving on to a murine, or other host.  
 
One of the shortcomings of this study that needs to be addressed is the loss of the 
pMV158 plasmid, tagging S. pyogenes cells fluorescently, by a number of bacteria. 
More specifically, Figure 5.1 showed that about a third of the infectious dose, for the 
population dynamics experiment, lacked any fluorescence. To begin with, these 
bacteria need to be grown and plated always in the presence of antibiotic, something 
not carried out in this study. Another idea that could be explored could be the 
chromosomal integration of the fluorescent tags, or a choice of plasmid previously 
used in S. pyogenes that is known to not be so easily lost. Future experiments 
require to additionally test for any effects the presence of the plasmid might have on 
growth or virulence of these new strains when compared to their wild type 
equivalents. With that being said, much of the data of this study relied on work using 
these plasmids. Most of the experiments sought to elucidate the basic interactions 
between phagocytes, pathogen, and augmented material in a heavily qualitative 
manner, which somewhat addresses this shortcoming. The one experiment that 




and neutrophils, S. pyogenes was instead labelled with an AlexaFluor dye (Chapter 
5). 
 
6.2 Setting up the model 
 
One of the biggest issues when investigating S. pyogenes infections is choosing a 
strain to work with. There are many different S. pyogenes strains, and many of them 
have been characterised to exhibit tissue tropisms, which alludes to differences in 
the virulence factors deployed during infection (Bessen and Lizano, 2010). Most 
studies examine emm1 isolates, as it is the single most successful and widespread 
type. For my study, three strains were used; H293 (emm89), H305 (emm1), and 
HSC5 (emm14). They were selected on the premise of prevalence and clinical 
relevance (emm89, emm1), as well as being extensively used in zebrafish studies 
(emm14).  
 
6.3 Describing the S. pyogenes infection dynamics 
 
S. pyogenes H293, at a dose of about 1500 CFU injected at 2 dpf, yields 
approximately 50% survival after 3 days. In the case of HSC5, 50% survival wasseen 
at 500 CFU, while H305 showed the highest virulence with 70 CFU resulting in 25% 
survival. What is interesting, however, is that for H293, bacterial growth was 
restricted by the host until almost 8 hpi, but at 20 hpi, that was no longer the case. 




with high bacterial loads were associated with mortality. H293 was subsequently 
chosen for further studies, due to its amenability to study as well as clinical relevance 
(Chapters 4, 5). H293 is amenable to studying pathogenesis in the zebrafish embryo 
model, given the nature of the time window available during fish development.  
 
6.4 Phagocytes mediate a temporary bottleneck during infection 
 
In order to discover the nature of the host-associated bacterial growth restriction 
(bottleneck), microscopy was used. Data indicated that phagocytes had taken up 
most of the bacteria as early as 0.5 hpi, with very few if any extracellular bacteria 
visible. By 6 hpi macrophages completely saturated with bacteria were observed, 
with the load being almost as big as the cell itself. This would suggest subsequent 
lysis of the macrophages, and release of live S. pyogenes, which matches what was 
observed at 8 hpi. The pathogen could then disseminate and form multiple lesions, 
eventually overwhelming the host. Depleting phagocytes, resulted in a dramatically 
faster host survival drop, and microscopy demonstrated that bacteria were much 
more spread, when compared to the control. Taken together, this data further 






6.5 S. pyogenes can replicate inside phagocytes 
 
It is apparent that the phagocytes are able to temporarily control S. pyogenes 
growth. Fluorescence images also suggest that the bacterial numbers, within the 
macrophages, increase over time. Albeit, this study not being able to assess if this 
increase came from intracellular growth or from continued phagocytosis, it was 
shown that S. pyogenes is able to not only persist, but also replicate within 
macrophages (Hertzén et al., 2010, O’Neil et al., 2016), neutrophils (Medina et al., 
2003), and pharyngeal epithelial cells (Osterlund et al., 1997). However, there is no 
previous evidence of this in zebrafish macrophages. 
 
Despite the fact that many previous studies worked with emm1 type S. pyogenes 
strains, there was one that reported that the H293 emm89-type strain, could 
replicate within HeLa cells (Thurston et al., 2009). Another group, investigating 
severe invasive S. pyogenes soft tissue infections, reported macrophages to act as 
the primary reservoir for viable intracellular S. pyogenes, even during antibiotic 
treatment of the patient. This “trojan horse” approach has also been described for 
Streptococcus iniae (Zlotkin et al., 2003), and S. aureus (Gresham et al., 2000). 
Hence, although phagocytes provide protection of the host against pathogens, they 
can also be used as a shelter to ensure the survival of the pathogen, that eventually 
emerges to overwhelm the host. While, S. pyogenes has been described to use 
phagocytes as a reservoir to withstand assault (Thulin et al., 2006), this was not 
observed in the systemic infection zebrafish embryo model, as it was in the model 




6.6 Pathogen population dynamics reveal polyclonality 
 
In the case that the events occurring inside the phagocytes, favour the pathogen, S. 
pyogenes replicates, gets released, and begins forming lesions. In a mixed infection 
using the same H293 strain with different fluorescent labels, no clonality was 
observed, as the lesions formed were of mixed colours. Given the nature of this 
bottleneck, and how adept S. pyogenes is at combating the phagocytes, this results 
in a polyclonal infection.  
 
6.7 Augmenting material does not affect S. pyogenes infection 
 
Some S. pyogenes infections occur within a polymicrobial environment that is the 
microbiome. It was therefore tested if other microbes, and their constituent 
components might alter host-pathogen dynamics. To this end, the effect of different 
types of peptidoglycan and live M. luteus were used to try and emulate the natural 
instance as much as possible. This choice of augmenting material was reported to 
increase the mortality of fish, when mixed with an S. aureus dose that does not 
produce such pathogenicity alone (Boldock et al., 2018). Unlike in S. aureus 
however, none of the aforementioned material was able to augment S. pyogenes 
infection. Pathogenesis of S. pyogenes was formally augmented by peptidoglycan, 
but this seems due to overwhelming the immune system rather than a more specific 
process, as was discovered in S. aureus. This highlights differences in the cellular 




back by the phagocytes with no clonal expansion ensuing. This suggests that the 
treatment and outcome of the pathogens by phagocytes is different as the 
pathogens have different means of infecting.  
 
6.8 S. pyogenes infection model hypothesis 
 
Other infection models in zebrafish embryos, have reported bottlenecks before, 
including S. enterica, Borellia species, S. aureus, E. faecalis (Grant et al., 2008, 
Prajsnar et al., 2012, Prajsnar et al., 2013, Rego et al., 2014). It is hence clear that 
the bottleneck effect will appear with any immunocompetent host. The following 
question then is, what kind of bottleneck occurs for each pathogen.  
 
Zebrafish mortality data shows that this is the order of how successfully these strains 
cause infection: S. pyogenes H305 (emm1)>S. pyogenes HSC5 (emm14)>S. 
pyogenes H293 (emm89). Only H293 had a distinct bottleneck, whereas for the two 
first strains no bottleneck was observed at the time-points used. For H293, S. 
aureus, and E. faecalis, the population bottleneck within the host is phagocyte-
associated (Prajsnar et al., 2012, 2013). The molecular interactions which control 
this process are unknown for all three species. My study allows me to propose a 






Despite a number of zebrafish embryo studies having been reported, including for 
Burkholderia cenocepacia and Pseudomonas aeruginosa (Brannon et al., 2009, 
Vergunst et al., 2010), their infectious doses and resulting mortality have not been 
connected to their respective bacterial in vivo kinetics and phagocyte behaviour. As 
a result, I will use the S. aureus model for comparison. In S. aureus, a dose of 1200 
CFU in 1 day old fish results in 50% host mortality after 4 days (Prajsnar et al., 2008). 
Phagocytes restrict bacterial growth until almost 48 hpi, at which time-point there 
were two distinct host populations with a 103 difference in bacterial load. These 
higher bacterial numbers were associated with the fish succumbing to infection.  
 
The hypothesis that I suggest here is that the fate of the host is determined within 
the phagocytes, while the presence of extracellular S. pyogenes also exerts 
additional pressure on the immune system (Figure 6.1). The greater the number of 
bacteria overcoming the defences of their phagocytes, and managing to replicate 
intracellularly, the greater the number of extracellular S. pyogenes will be to form 
lesions. Eventually, the amount of extracellular S. pyogenes will overwhelm the host. 
 
6.9 Future directions 
 
The effect of neutrophil ablation during S. pyogenes infection 
Although my study employed techniques to ablate macrophages to investigate the 
role of phagocytes against S. pyogenes infection, ablation of neutrophils was not 




fish line, that has a cell type genetically tagged, to break the prodrug down, into a 
toxic chemical that will ablate the targeted cell type. This approach was used, as 
seen in Chapter 4, but it also rendered wildtype more susceptible to infection. An 
alternative would be to use morpholinos to knock-down the colony-stimulating factor 
3 receptor (CSF3R), and its two cytokine ligands coded by csf3a and csf3b, to 
reduce neutrophil numbers in zebrafish embryos (Pazhakh et al., 2017). CSF3, also 


















Figure 6.1 Diagram of the S. pyogenes systemic model of infection 
A conceptual model of the S. pyogenes infection based on the results of S. pyogenes H293. 
S. pyogenes is phagocytosed within 0.5 hpi. At about 10 hpi, the bottleneck is resolved, and 
the bacterial numbers begin to alter from the infectious dose. At 24 hpi (75% survival), and 
until the end of the experiment (66 hpi - 50% survival), two very distinct host populations 
can be seen in terms of bacterial load. The group with the high bacterial numbers, with the 
bacteria that managed to pass through the bottleneck, has succumbed. In contrast, the other 






Analysis of the host response to S. pyogenes 
As described in Chapter 1, MyD88 has been found to be required for the host to 
mount an effective phagocyte-mediated inflammatory response to S. pyogenes, and 
further phagocyte recruitment (Loof et al., 2008, 2010). Levels of TNF, IL-6, IL-12, 
and type I interferons (IFNs) were significantly lower in mice lacking MyD88 (Gratz 
et al., 2008, 2011; Loof et al., 2008, 2010). This was shown to render the neutrophils 
unable to migrate to the site of infection, and make the host more susceptible to S. 
pyogenes infection. Reduced amounts of TNF were also suggested to be 
associated with reduced macrophage recruitment (Mishalian et al., 2011). 
Regardless of MyD88 being reported to be involved in the defence against S. 
pyogenes, and a study showing that TLR2 and TLR13 are not redundant in vivo, it 
is still not clear which human TLRs are deployed (Fieber et al., 2015). This is 
because although TLR2 is a highly conserved receptor in vertebrates, TLR13 is only 
present in mice and rats, making them naturally resistant to S. pyogenes. Therefore, 
future experiments would be to interrogate the role of host factors in disease. The 
myd88 gene has been successfully identified in zebrafish and disrupted by a loss-
of-function morpholino (Meijer et al., 2004, 2005, van der Sar et al., 2006). 
 
Analysis of S. pyogenes virulence factors and their interaction with the host 
SpeB is considered one of the major S. pyogenes virulence factors and has been 
reported to be secreted by most invasive disease clinical isolates (Olsen et al., 2015, 
Laabei and Ermert, 2018). It was demonstrated to be able to degrade the C3 
component of the complement system, and resist neutrophil killing, with additional 




Ogawa et al., 2013). Therefore, combinatorial studies, of speB mutants and 
morpholino knock-down fish of complement components, could be used following 
this study to elucidate host-pathogen interactions. Other S. pyogenes virulence 
factors that interfere with complement, that could be explored are fibronectin-binding 
protein Sfb1/PrtF1 (surface bound), ScpA (secreted) and GAPDH (secreted) (Terao 
et al., 2006, Hyland et al., 2007). Sfb1/PrtF1 was found to decrease C3b deposition, 
whereas both ScpA and GAPDH degrade C5a.  
 
In vivo infection dynamics 
My studies have revealed a complex cellular interaction between S. pyogenes and 
the host. In order to further elucidate this interplay, it is important to follow this in real 
time. Only the zebrafish embryo model permits this by virtue of the transparent 
nature of the host, and the ability to visualise bacteria during infection. The light 
sheet microscope (Amich et al., 2019) allows determination of real-time interactions 
throughout infection using labelled host and bacterial cells. By studying the 
phagocytes that control, or do not control, S. pyogenes, it will be possible to begin 
to determine this crucial break point. In the future, unravelling mechanisms of 
successful host control of pathogens will allow their manipulation as adjuncts to 
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